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Abstract
This dissertation explores the estimation of endogenous treatment effects in the presence of het-
erogeneous responses. A Bayesian Nonparametric approach is taken to model the heterogeneity in
treatment effects. Specifically, I adopt the Dirichlet Process Mixture (DPM) model to capture the
heterogeneity and show that DPM often outperforms Finite Mixture Model (FMM) in providing
more flexible function forms and thus better model fit. Rather than fixing the number of compo-
nents in a mixture model, DPM allows the data and prior knowledge to determine the number of
components in the data, thus providing an automatic mechanism for model selection.
Two DPM models are presented in this dissertation. The first DPM model is based on a two-
equation selection model. A Dirichlet Process (DP) prior is specified on some or all the parameters
of the structural equation, and marginal likelihoods are calculated to select the best DPM model.
This model is used to study the incentive and selection effects of having prescription drug coverage
on total drug expenditures among Medicare beneficiaries.
The second DPM model utilizes a three-equation Roy-type framework to model the observed
heterogeneity that arises due to the treatment status, while the unobserved heterogeneity is handled
by separate DPM models for the treated and untreated outcomes. This Roy-type DPM model is
applied to a data set consisting of 33, 081 independent individuals from the Medical Expenditure
Panel Survey (MEPS), and the treatment effects of having private medical insurance on the outpa-
tient expenditures are estimated.
Key Words: Treatment Effects, Endogeneity, Heterogeneity, Finite Mixture Model, Dirichlet
vi
Process Prior, Dirichlet Process Mixture, Roy-type Modeling, Importance Sampling, Bridge Sam-
pling
vii
1 Introduction
The central issue studied in this dissertation is the estimation of causal treatment effects. Treatment
effects measure the effectiveness of treatment, or the difference between the outcomes with and
without treatment. The treatment in question can be any form of binary intervention. For example,
the decision to purchase a medical insurance policy is such a treatment, and we are interested in
the difference in medical resource utilization between those with and without coverage. Another
example would be to evaluate the effectiveness of a job training program, where we want to find out
the difference in earnings between those who have participated in the training program and those
who have not.
Formally, let Y1 denote the outcome with treatment and Y0 the outcome without treatment. Since
an individual cannot be in both states, only one of the two outcomes is observed for that individual,
with the other one being the counterfactual. Let D be the binary treatment variable. Define D = 1
if the individual is in the treatment group, and D = 0 if it is not. The realized outcome Y is thus
defined as:
Y =

Y0 if D = 0
Y1 if D = 1
or
Y = DY1 + (1−D)Y0 (1.1)
and the treatment effect is defined as Y1 − Y0.
When evaluating treatment effects, economists often have to work with observational data where
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a nonrandom sample is almost never the case, unlike drug trials where patients are randomly as-
signed into treatment and control groups. This lack of a random sample in observational data is one
of the classic sources of endogeneity, and is often at the center of causal inference. A variable is said
to be endogenous if it is correlated with the error term. Endogeneity can arise from issues such as
the nonrandom samples mentioned above, measurement error, omitted variables, simultaneity, etc.
When estimating endogenous treatment effects, naive Ordinary Least Square (OLS) estimates
will be biased. In the example of medical insurance coverage, the OLS estimates will be upwardly
biased if those who have the coverage would have spent more than those who do not, even if they
had not bought the coverage in the first place. The difference between OLS estimates and the actual
treatment effects is called selection bias or selection effect.
To understand why the OLS estimates are biased in this case, define simple linear regression
models for both outcomes:
Y1 = Xβ1 + U1 (1.2)
Y0 = Xβ0 + U0 (1.3)
where X are covariates, U0 and U0 are error terms after controlling X for each outcome, and β0
and β1 are the corresponding parameters on the covariates. Substituting equations (1.2) and (1.3)
into (1.1), we have:
Y = DY1 + (1−D)Y0
= DXβ1 +DU1 + (1−D)Xβ0 + (1−D)U0
= Xβ0 +D(Xβ1 −Xβ0 + U1 − U0) + U0
Denoting α = Xβ0, γ = Xβ1 −Xβ0 + U1 − U0, and ε = U0, we have a simple linear regression
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model:
Y = α+ γD + ε (1.4)
where γ is the treatment effect estimated from OLS. IfD is endogenous, i.e., the covariance between
D and the error term ε, Cov(D, ε), is not 0, then the OLS estimates are biased.
To address selection bias, or endogeneity in a general sense, the Instrumental Variable (IV)
approach is often employed by econometricians. Suppose we have an instrument Z that satisfies the
traditional IV definitions:
Cov(Z,D) 6= 0
Cov(Z, ε) = 0
then the IV method will produce a consistent estimator of the treatment effect γ:
plim βˆiv =
Cov(Z, Y )
Cov(Z,D)
= γ
Separating selection biases from treatment effects empirically, however, is not an easy task.
While IV estimation is a powerful tool in economists’ toolkit, it is, at the same time, a tool where
great care is needed to make sure the instruments are used properly. The validity of instruments,
by definition, hinges on the assumption that the instruments are not correlated with the disturbance
term in the equation of interest – something that calls for great diligence and scrutiny. In practice,
intuition and pretesting are usually employed by researchers to evaluate the validity of chosen in-
struments. “We can never entirely dispel the clouds of uncertain validity that hang over instrumental
variable analyses, but we should chase away what clouds we can” (Murray, 2006).
A much bigger challenge of IV estimation – when used to infer causal treatment effects – comes
from the situation where the responses are heterogeneous. Heckman et al. (2006) show that validity
of interpreting IV estimates as meaningful treatment effects depends on an important assumption:
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the homogeneity of responses after controlling for the observables. If the treatment effect, condi-
tional onX , is heterogeneous, i.e., individuals self-select into treatment based on their idiosyncratic
gains, the IV method breaks down in that it does not identify mean treatment effects. In such cases
of selection on gains, the treatment is not exogenous because it is correlated with the gains. As a
result, the average treatment effects are not identified even with a valid instrument.
To show why this is the case under heterogeneous responses, denote γ as the mean treatment
effect, and η as the idiosyncratic gains:
γ = Xβ1 −Xβ0 (1.5)
η = U1 − U0 (1.6)
Plugging (1.5) and (1.6) into (1.4) we have:
Y = α+ γD + (ε+ ηD) (1.7)
In the case of selection on gains, η and D are not statistically independent, and as a result the
conditional expectation of the second term of the error in (1.7), ηD, on the instrument Z, is not
zero:
E(ηD | Z) = E(η | D = 1, Z)Pr(D = 1 | Z) (1.8)
The left hand side of (1.8) is not zero because the first term at the right hand side is not zero
due to selection on gains. Heckman et al. (2006) refer to this situation as the presence of essential
heterogeneity. They show that, under heterogeneous responses, the IV estimator in general does not
identify any mean treatment effects. In such cases, different instruments identify different economic
parameters, and there is no assurance that the IV estimator will be less biased than OLS.
Specifically, Heckman and Vytlacil (2005) show that the standard linear IV estimator, as well
as the average treatment effect (ATE) and the average treatment effect for the treated (ATT), can
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be interpreted as a weighted average of marginal treatment effect (MTE), which is defined as the
average treatment effect for those that are indifferent to treatment given a fixed amount of unob-
servable utility of being treated. In order to be able to interpret the IV estimator as a meaningful
average treatment effect, we have to ensure that the weights on the MTE are positive. In the pres-
ence of response heterogeneity, the weights are guaranteed to be nonnegative if the instrument is the
propensity score itself, or a monotonic transformation of the propensity score – with the propensity
score defined as the probability of receiving treatment. This underscores the central role that the
propensity score plays in the IV estimation for treatment effects, and takes away the robustness to
misspecification of the selection equation that is enjoyed by IV estimation under homogeneous re-
sponses where any valid instrument, as long as it satisfies the traditional definitions of IV, is able to
identify the same underlying economic parameters of interest (Heckman et al., 2006).
It is thus of great importance that the heterogeneity in the data is modeled accurately. In this dis-
sertation, I take a Bayesian Nonparametric approach to model the heterogeneity in treatment effects.
Specifically, I adopt the Dirichlet Process Mixture (DPM) model to capture the heterogeneity and
show that DPM often outperforms Finite Mixture Model (FMM) in providing more flexible func-
tional forms and thus better model fit. Rather than fixing the number of components in a mixture
model, DPM allows the data and prior knowledge to determine the number of components in the
data, thus providing an automatic mechanism for model selection.
Two DPM models are presented in this dissertation. The first DPM model is based on a two-
equation selection model. The motivation is to identify potential homogeneous components within
the data. The homogeneity assumption in responses within each of those components is much more
realistic and defensible, thus any instrument, as long as it satisfies the traditional definitions of IV,
will be able to identify the same underlying economic parameters of interest. A Dirichlet Process
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(DP) prior is specified on some or all the parameters of the structural equation, and marginal likeli-
hoods are calculated to select the best DPM model. The application for this model is to estimate the
endogenous treatment effects of having prescription drug coverage on drug expenditures. The sam-
ple consists of 2, 309 distinct Medicare beneficiaries who enrolled into Medigap plans from 2003
and 2005. The average treatment effect and average treatment effect for the treated are estimated as
$1, 132 and $858 respectively. This is consistent with the findings from Fang et al. (2008) where
they find substantial advantageous selection effects in the Medigap insurance market.
The two-equation DPM selection model works well for data sets where the treatment group and
the control group are not too far apart from each other. If this is not the case, then a model with
Roy-type selection is warranted. Thus, in the second DPM model, I utilize a three-equation Roy-
type framework to model the observed heterogeneity that arises due to the treatment status, while
the unobserved heterogeneity is handled by separate DPM models for the treated and untreated
outcomes. I apply the Roy-type DPM model to a data set derived from the 2002-08 Medical Ex-
penditure Panel Survey (MEPS), the latest seven years of data that are available from the MEPS
website, and estimate the treatment effects of having private medical insurance on outpatient expen-
ditures. The outpatient expenditures are calculated as the total medical expenditures minus hospital
expenditures. With the Roy-type DPM model, I find that there exist strong incentive effects, with
the average treatment effect and average treatment effect for the treated estimated as $799 and $764
respectively. One interesting finding is that the selection effects are quite small after heterogeneity
is adequately modeled.
The remainder of this dissertation is organized as follows: Chapter 2 provides a short introduc-
tion to the Markov Chain Monte Carlo (MCMC) algorithm. Different marginal likelihood calcula-
tion methods are also discussed. Chapter 3 reviews the literature of treatment effects, the Dirichlet
6
Process prior, and the Dirichlet Process Mixture models. Chapter 4 presents the two-equation DPM
selection model and its application to the prescription drug expenditure data set. Chapter 5 presents
the Roy-Type DPM model and its application to the data set of outpatient expenditures. Concluding
remarks and proposals for future research are discussed in Chapter 6.
7
2 Bayesian Econometrics
2.1 MCMC Algorithm and Gibbs Sampler
In this section, I provide a short introduction to the most commonly used posterior sampling tech-
niques in modern Bayesian inference, namely the MCMC algorithm, and the associated Gibbs sam-
pler.
The basic idea behind the MCMC method is to construct a Markov chain on the space of the
parameter of interest. A Markov chain specifies a method for generating a sequence of random
variables {θ1, θ2, · · · , θr · · · } starting from some initial point θ0. The sequence is generated by
some transition probabilities for the chain to move from one state to another. The transition kernel
is specified by choosing the conditional distribution θr+1 | θr or θr | θr+1, where r stands for the
current state, and r + 1 the next state. The key requirement to construct such a chain is that one
must choose the transitional kernel for the chain in such a manner that the stationary distribution
of the kernel is indeed the target distribution. A desirable property of a stationary distribution is
ergodicity, i.e., the average of an ergodic Markov chain converges to the expectation with regard to
the stationary distribution.
The Gibbs sampler is a Markov chain generated by iterating through a set of conditional dis-
tributions of the joint posterior distribution. The idea is to break the joint posterior into groups
of parameters, so that the conditional distribution of the parameters in each group is analytically
8
tractable. Denote the complete parameter vector as θ, and the posterior kernel is as follows:
p(θ | y) ∝ p(θ)p(y | θ)
where p(θ) is the prior and p(y | θ) is the likelihood. If this kernel density is not of any known
analytical form, we cannot draw directly from it. But if we split θ into two blocks:
θ′ = (θ1, θ2)
and the following two conditionals are tractable:
p(θ1 | y, θ2)
p(θ2 | y, θ1)
then, under very mild conditions, the Gibbs sampler illustrated below will be assured to generate an
ergodic chain:
• Start with some initial value for θ1, denoted as θ01.
• Draw value for θ02 from p(θ2 | y, θ01).
• Draw value for θ11 from p(θ1 | y, θ02).
• Repeat this process until enough draws are obtained.
2.2 Marginal Likelihood Calculation
It is well known that calculating the marginal likelihood for mixture models is not a trivial task. The
Harmonic mean estimator – a natural byproduct of MCMC algorithms and thus the easiest one to
calculate – is known to be unstable for mixture models.
9
Based on Bayes’s rule, the marginal likelihood is the normalizing constant of the posterior dis-
tribution:
p(y |Mk) = p(y | θk)p(θk)
p(θk | y) (2.1)
Chib (1995) provides an approximation of equation (2.1):
pˆ(y |Mk) ≈ p(y | θ
∗
k)p(θ
∗
k)
p(θ∗k | y)
(2.2)
where θ∗k can be an arbitrary point of θk. For efficiency, θ
∗
k is often selected in high density areas.
Chib shows that the posterior ordinate p(θ∗k | y) can be calculated without much additional program-
ming or computation time within a Gibbs sampler. In the case of Metropolis-Hastings sampling,
Chib and Jeliazkov (2001) provide a generalized estimator of the Chib (1995) method.
Chib’s method, however, can be biased for calculating marginal likelihoods for mixture models.
Since Chib’s method estimates the marginal density from the mean of conditional densities, it is
essential that the posterior draws mix well and the chain visits the whole parameter space. In the
case of FMM, that means the MCMC chain needs to explore all K! modal regions, which is not
necessary the case for Gibbs samplers on which Chib’s method is based. Indeed, Neal (1999) points
out in a simulation that the bias of Chib’s method is exactly −log(K!).
Given this potential issue of Chib’s method, Fruhwirth-Schnatter (2006) argues that, for mixture
models, sampling-based techniques are particularly effective in estimating the marginal likelihood.
The key issue is to construct an importance density that meets several criteria:
• The construction of this density should be somewhat automatic, without much manual tuning.
• It should be relatively easy to sample from this importance distribution.
• The importance density constructed should be a rough approximation to the posterior distri-
bution.
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Since the posterior distribution for FMM is usually multimodal, a multimodal importance density
seems to be appropriate. Fruhwirth-Schnatter (2001) shows that a random subsequence of MCMC
draws is a good candidate for importance density, and it can be fully automated and integrated into
the algorithm of MCMC sampling.
With a good candidate for the importance density, there are at least three simulation-based esti-
mators for marginal likelihood:
• The Importance Sampling (IS) estimator of the marginal likelihood is defined as follows:
pIS(y |Mk) =
∫
p(y | θk)p(θk)
q(θk)
q(θk)dθk (2.3)
where p(y | θk) is the likelihood, p(θk) is the prior density, and q(θk) is the importance
density. A sample drawn from the importance density, which itself is constructed as a random
subsequence of MCMC draws, is as follows:
θ
(l)
k ∼ q(θk), l = 1, · · · , L
The sample analogue of (2.3) can be computed as follows:
pˆIS(y |Mk) = 1
L
L∑
1
p(y | θ(l)k )p(θ(l)k )
q(θ(l)k )
Even with a good importance density, the IS estimator can be unstable: In order for the
variance of the IS estimator to be finite, the importance density has to be fatter than the
posterior density in the tails – something we cannot ensure for mixture models.
• The Reciprocal Importance Sampling (RI) estimator of the marginal likelihood is defined as
follows:
pRI(y |Mk) =
∫
q(θk)
p(y | θk)p(θk)p(θk | y,Mk)dθk (2.4)
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where p(θk | y,Mk) is the normalized posterior density. A random sample from posterior
MCMC draws is denoted as follows:
θ
(m)
k ∼ p(θk | y,Mk),m = 1, · · · ,M
The sample analogue of (2.4) can be computed as follows:
pˆRI(y |Mk) =
(
1
M
M∑
1
q(θ(m)k )
p(y | θ(m)k )p(θ(m)k )
)−1
Similarly, the RI estimator can be unstable due to the possible explosion of its variance – we
need to make sure the importance density is thinner than the posterior density in the tails,
which again is not something we can ensure for mixture models.
• In light of the potential problem of unbounded variances for IS and RI estimators, Fruhwirth-
Schnatter (2006) proposes the Bridge Sampling (BS) estimator based on the bridge sampling
method introduced by Meng and Wong (1996). In a sense BS is a generalization of IS in a
way that the posterior MCMC draws are combined with the draws from importance sampling.
Formally the BS estimator is defined as:
pBS(y |Mk) = Eq(α(θk)p(y | θk)p(θk))
Ep(α(θk)q(θk))
(2.5)
For the denominator, the expectation is taken with regard to the importance density; and for
the numerator, the expectation is with regard to the posterior density.
The sample analogue of (2.5) then can be computed as follows:
pˆBS(y |Mk) =
L−1
∑L
1 (α(θ
(l)
k )p(y | θ(l)k )p(θ(l)k ))
M−1
∑M
1 (α(θ
(m)
k )q(θ
(m)
k ))
It can be seen that the BS estimator uses both importance sampling draws and posterior draws
in calculating the marginal likelihood, and Fruhwirth-Schnatter (2004) shows that the vari-
ance of the BS estimator is always bounded, thus making the BS estimator a much more
stable one.
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3 Literature Review
3.1 Treatment Effects
The literature on treatment effects is vast, both in the theoretical and empirical fronts. In particular,
the last two decades have seen a great body of work in this area. Sometimes this literature is also
referred to as program evaluation, a term that originates from social studies where the effectiveness
of some social program is of interest to the researchers. The central problem studied in this liter-
ature is to compare the outcomes of two groups of units or individuals, the control and treatment
groups. For economists groups can be economic agents such as households, individuals, firms, or
nations, and example treatments can be a housing subsidy program, purchase of an insurance policy,
enforcement of one regulation, or adoption of some policy, respectively. Of particular interest is the
situation where the treatment is binary – people choose to participate in a social program, or decide
whether or not to buy insurance coverage. The differences in the outcomes between the treatment
unit and the control unit – a measure of the effectiveness of a social program – is referred to as the
treatment effect.
The treatment effect literature in statistics comes from randomized experiments, going back
to Fisher and Neyman’s work on the design of randomized experiments in 1920s. From the very
beginning this literature takes the approach of potential outcomes, pioneered by Rubin. In a series of
papers, Rubin formulated the approach of estimating the treatment effects in observational studies
by comparing the potential outcomes of the same unit, rather than relying only on the observed
13
outcome (Imbens and Wooldridge, 2009). This model is often referred to as Rubin’s model, or the
Rubin Causal Model (RCM)(Holland, 1986).
For econometricians a more familiar term is Roy’s model, or the switching regression model.
Roy (1951) developed a model to explain occupational choice and its impact on earnings, hence
the name Roy’s model. Econometricians, in order to make some causal inference, are often more
concerned with the issue of endogeneity. In labor economics, for example, the effectiveness of job
training programs has been the most prominent application where the concern for self-selection is
often the focal point of estimation (Ashenfelter, 1978; Ashenfelter and Card, 1985; Card, 1988;
LaLonde, 1986).
In a general sense there are two categories of estimators for treatment effects. The first set
hinges on the assumption of exogeneity. This assumption goes by many names in the literature:
unconfoundedness, ignorability of treatment, or selection on observables. The idea behind this
assumption is that, after conditioning on observed covariates X , the treatment does not depend on
the outcomes:
Y1, Y0 ⊥ D | X (3.1)
where ⊥ stands for independence.
Under the assumption of unconfoundedness, there are many parametric and nonparametric es-
timators for treatment effects: regression, kernel matching, propensity score, or combinations of
them, with nonparametric estimation methods being the research focus. Imbens and Wooldridge
(2009) provide a complete review of estimating treatment effects under unconfoundedness, and Im-
bens (2004) reviews the nonparametric estimation of average treatment effects under exogeneity. A
desirable feature of the estimators in the first category is that no distribution assumptions are needed
for estimation. However, that flexibility comes with a huge burden – the assumption of ignorability,
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which is often violated in economic analyses with observational data.
A slightly weaker assumption is the conditional constant effects, or homogeneous responsive-
ness:
(Y1 − Y0) ⊥ D | X (3.2)
Under this assumption the outcomes are correlated with the treatment variable, but the correla-
tion is assumed to be the same for both outcomes, thus the difference is independent of the treatment,
conditional on covariates X . This assumption essentially rules out the Roy-type selection bias, and
the traditional Instrumental Variable (IV) estimator is a consistent estimator for the mean treatment
effect.
If we cannot make the unconfoundedness or conditional constant effect assumption – this is
sometimes referred to as selection on unobservables – then the average treatment effects, in general,
are not identified without some distributional assumptions on the error terms. Under the framework
of latent utility, Heckman et al. (2001) provide a comprehensive exposition of various treatment
effects with selection bias. The selection equation is specified as follows:
D∗ = Zθ + UD (3.3)
where D∗ is the latent utility of receiving treatment, UD is the error term, and Z is the instrument.
The latent variable D∗ determines the treatment decision based on the following rule:
D(Z) = I(D∗ > 0) = I(Zθ + UD > 0)
where I(A) is the indicator function that takes the value 1 if the event A is true.
The three equation framework – two outcome equations (1.2) and (1.3), defined in the intro-
duction, and the selection equation defined above, provide a canonical model for defining the four
common treatment effects of our interest:
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• Average treatment effect (ATE). ATE is defined as the expected gain from treatment for a
randomly selected individual:
ATE(x) = E(∆ | X = x) = x(β1 − β0)
ATE = E(∆) =
∫
ATE(X)dF (X) ≈ 1
n
n∑
i=1
ATE(xi) = x(β1 − β0)
• Treatment effect for the treated (TT). TT is the average gain from treatment for those who
receive the treatment:
TT (x, z,D[z] = 1) = E(∆ | X = x, Z = z,D[z] = 1)
= x(β1 − β0) + E(U1 − U0 | UD + zθ > 0, X = x, Z = z)
= x(β1 − β0) + E(U1 − U0 | UD + zθ > 0)
TT = E(∆ | D[z] = 1) =
∫
TT (X,Z,D[Z] = 1)dF (X,Z|D[Z] = 1)
≈ 1
n
n∑
i=1
DiTT (xi, zi, D[zi] = 1)
• Local Average Treatment Effect (LATE). LATE is a concept proposed by Imbens and Angrist
(1994). It is defined as the gain from those who are induced to receive treatment with some
change of the instrument variables, but otherwise would not. It is the average treatment effect
of the “compliers”.
LATE(x,D[z] = 0, D[z′] = 1) = E(∆ | X = x,D[z] = 0, D[z′] = 1)
= x(β1 − β0) + E(U1 − U0 | −z′θ < UD < −zθ,X = x)
= x(β1 − β0) + E(U1 − U0 | −z′θ < UD < −zθ)
LATE = E(∆ | D[z] = 0, D[z′] = 1) =
∫
LATE(X,D[z] = 0, D[z′] = 1)dF (X)
≈ 1
n
n∑
i=1
LATE(xi, D[z] = 0, D[z′] = 1)
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• Marginal Treatment Effect (MTE). MTE is defined as the gains from those who are just indif-
ferent, given a fixed unobservable utility uD, between receiving treatment or not. Intuitively,
MTE can be interpreted as the LATE in the limit, or LATE as a discrete approximation of
MTE.
MTE(x, uD) = E(∆ | X = x, UD = uD)
= x(β1 − β0) + E(U1 − U0 | UD = uD, X = x)
= x(β1 − β0) + E(U1 − U0 | UD = uD)
MTE(uD) =
∫
MTE(X,uD)dF (X) ≈ 1
n
n∑
i=1
MTE(xi, uD)
= x(β1 − β0) + E(U1 − U0 | UD = uD)
These four parameters generally estimate different average treatment effects, and the economic
issue in question will dictate which parameter is the most relevant one.
In order to identify and estimate the four treatment effects defined above, some distributional
assumptions are needed. If we impose a trivariate normal distribution among the three error terms
as follows: 
UD
U1
U0
 ∼
0,

1 σ1D σ0D
σ1D σ
2
1 σ10
σ0D σ10 σ
2
0


then there are closed form solutions for all four parameters:
ATE(x, z,D[z] = 1) = x(β1 − β0)
TT (x, z,D[z] = 1) = x(β1 − β0) + (σ1D − σ0D)φ(zθ)Φ(zθ)
LATE(x,D[z] = 0, D[z′] = 1) = x(β1 − β0) + (σ1D − σ0D) φ(z
′θ)− φ(zθ)
Φ(z′θ)− Φ(zθ)
MTE(x, z,D[z] = 1) = x(β1 − β0) + (σ1D − σ0D)uD
(3.4)
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where φ(.) and Φ(.) are the probability density function and cumulative probability of the standard
normal distribution. From (3.4) we can see that, under the assumptions of (3.1) or (3.2), all four
parameters are identical.
This textbook solution is often too restrictive and unrealistic. With Bayesian methods, we can
relax the trivariate normal distribution by allowing more flexible function forms, while still enjoying
the computational tractability of MCMC algorithms. Especially interesting cases are those where
some form of mixture models are utilized to model the joint distribution of the error terms. A few
notable mixture models in the Bayesian treatment effect estimation are as follows:
• Albert and Chib (1993) propose a Roy-type model where a multivariate-t distribution is as-
sumed for the joint distributions among error terms:
UiD
Ui1
Ui0
 ∼
0, λ
−1
i

1 σ1D σ0D
σ1D σ
2
1 σ10
σ0D σ10 σ
2
0


where
λi ∼ Gamma(v/2, v/2)
resulting in a marginal distribution of multivariate-t.
• Chib and Hamilton (2000) use FMM approach to model the joint distribution of outcomes
and latent utility (D∗, Y1, Y0):
d∗i
yi1
yi0
 ∼


z′iθj
x′iβj1
x′iβj0
 ,

1 σ1D σ0D
σ1D σ
2
1 σ10
σ0D σ10 σ
2
0

j

where
j = 1, · · · ,m
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and the number of components m is selected based on the marginal likelihood.
• Munkin and Trivedi (2010) (henceforth MT2010) adopt a FMM approach to model the hetero-
geneity in treatment effects. That model is a mixture model with a MNP probability equation,
in the spirit of Geweke and Keane (2007). There are three equations in the model:
1. Selection equation:
Di = Wiα+ ui (3.5)
such that
di = I{Di > 0},
and the marginal distribution of ui is assumed to be from the standard normal distribu-
tion:
ui
iid∼ N(0, 1)
the variance is set to 1 for identification since we do not observe Di.
2. Outcome equations:
Yij = Xiβj + ρjdi + δjui + εij (3.6)
with
εij ∼ N(0, σ2j )
where Yij (j = 1, 2) are two latent variables, and we only observe one of the two
outcomes.
3. Component probability equation:
Mi = Viγ+ξi (3.7)
with
ξi
iid∼ N(0, 1)
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and the ith individual is assigned to the first component if and only if Mi > 0 .
In studying the drug expenditures for elderly people, this model identifies two groups inter-
preted as the relatively healthy and relatively unhealthy within in the sample, and estimates
the incentive and selection effects for each group.
3.2 Dirichlet Process Mixture Model
The Dirichlet Process (DP) prior is the cornerstone of Bayesian nonparametric econometrics. It was
first introduced in the landmark paper Ferguson (1973). A DP prior is a prior defined on the space of
distribution functions – sometimes loosely referred to as “distribution over distribution”. It allows
for the support of the prior distribution to include all distributions on the real line.
Formally, a probability measure G is called a Dirichlet Process if, for any measurable partition
(A1, · · · , Ak) of the parameter space A, we have:
(G(A1), · · · , G(Ak)) ∼ Dirichlet(αG0(A1), · · · , αG0(Ak))
where Dirichlet stands for Dirichlet distribution, which is the multivariate generalization of the Beta
distribution. We denote the Dirichlet Process defined above as:
G ∼ DP (αG0)
where α is the precision parameter and G0 is the base distribution. It defines the “location” of the
DP prior. α controls the precision, or smoothness, of DP prior. A large value of α will produce a G
with many “atoms”, or clusters.
The benefits of the large support of the DP prior lead to a much wider range of shapes for
the posterior distribution by allowing the actual prior on the model parameters to stochastically
deviate from the baseline distribution. This is a very appealing feature in modeling unobserved
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heterogeneity, as the DP prior provides the flexibility of specifying multimodal, skewed, or fat-
tailed priors. As a result, the DP prior finds itself in wide use in many areas such as latent class
models, mixture models, clustering, and classification.
3.2.1 Po´lya Urn and Stick-breaking Representations of DP
Due to its infinite-dimensional nature, it is not easy to work directly with G. Instead it is often
marginalized to get the conditional or joint distributions of the parameters generated from DP. The
Po´lya Urn Scheme is such a representation of DP.
Assume G0 is a continuous distribution over colors, and each draw from G0 is a unique color.
Starting with an empty urn, we draw the first ball with a new color from G0 and put into the urn,
and the color of the subsequent ith draw, θi, is determined based on the following rules:
• With probability proportional to i−1 (i.e., the number of balls currently in the urn), randomly
take a ball from the urn, record its color and put it back, and also put another ball with the
recorded color into the urn.
• With probability proportional to α, draw a new color from G0 and put a ball with that new
color into the urn.
Blackwell and MacQueen (1973) show this representation results in the following prediction
rule:
θi | G ∼ G
G ∼ DP (αG0)
θi | θ1, · · · , θi−1 ∼ 1
i− 1 + α
i−1∑
j=1
δ(θj) +
α
i− 1 + αG0
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where δθj is a probability measure concentrated at θj .
It is important to note the clustering or grouping implied by the Po´lya Urn Scheme. Denote θ∗k as
unique values of all θi, Nk the size of kth cluster, and K the number of total clusters. In the Po´lya
Urn representation above, θ∗k corresponds to one unique color, θi the color of the ith ball, Nk the
number of balls with the kth color, and K the total number of unique colors. In terms of clusters,
the prediction rule can be rewritten as follows:
θi | θ1, · · · , θi−1 ∼ 1
i− 1 + α
K∑
k=1
Nkδ(θ∗k) +
α
i− 1 + αG0
where δθ∗k is a probability measure concentrated at θ
∗
k.
The clustering effect of DP is sometimes characterized as the Chinese Restaurant Process (CRP).
Consider a restaurant with infinitely many tables, and a new customer coming to the restaurant
prefers to join a table that already has many customers sitting there, but also with probability pro-
portional to α that he or she might start a new table. Some researchers refer to this characterization
as the “Collapsed” scheme since it deals with the clusters – or unique parameters θ∗k, rather than
each individual parameter θi drawn from DP.
Remarkably, Sethuraman (1994) shows DP can also be represented by an infinite stick-breaking
process, which characterizes DP as an infinite mixture model:
θi | G ∼ G
G =
∞∑
i=1
piiδ(θi)
pii = Vi
i−1∏
j=1
(1− Vj)
Vi ∼ Beta(1, α)
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where δ(θi) is a probability measure concentrated at θi. Visually, the stick-breaking procedure pro-
ceeds as follows:
1. Draw a new value, θi, from the baseline distribution G0.
2. Break what is left of the stick (For the first draw, it would be whole length of the stick) based
on Beta distribution Beta(1, α), and that length is the mixing weight of the newly drawn θi.
3. Repeat the previous two steps infinitely.
3.2.2 DPM and its Posterior Simulation
In practice, it is the clustering nature of DP that is used in most Bayesian nonparametric or semipara-
metric applications. A particularly popular model – in the sense of Bayesian hierarchical modeling
– is the DP Mixture Model (DPM) proposed by Lo (1984) and Ferguson (1983) :
yi | θi, xi ∼ f(θi, xi)
θi | G ∼ G
G ∼ DP (αG0)
where yi is the dependent variable, xi the covariates, f the conditional density of yi on xi, and θi the
parameter to be estimated. The baseline distribution G0 is often assumed to be from the Gaussian
family.
Even though the theoretical foundations of DP were laid decades ago, its practical applica-
tions were very limited due to the difficulties in sampling from the posterior. With development
of Markov chain methods, especially since the introduction of the Gibbs sampler (Gelfand and
Smith, 1990), many previous intractable models have become computationally feasible, and DPM
is a particular beneficiary of this development.
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Broadly speaking, there are two categories of samplers for DPM: marginal sampler and condi-
tional sampler, based on the Po´lya urn scheme and the stick-breaking representation respectively.
The marginal sampler does not work directly with G by marginalizing over it, thus it needs to cal-
culate the marginal densities of the data, which is not a trivial task if the baseline prior G0 is not
conjugate with the likelihood. Escobar and West (1995) and Escobar and West (1998) present a
practical algorithm for the Po´lya urn based sampler, but only for conjugate cases. Neal (2000) gives
eight algorithms for marginal samplers, especially addressing the nonconjugate cases:
• Algorithm #1 is a literal implementation of the Po´lya urn scheme which is quite inefficient.
• Algorithm #2 is the “Collapsed” sampler for conjugate cases.
• Algorithm #5 is based on Metropolis-Hastings sampling.
• Algorithm #8 is a Gibbs sampler based on auxiliary variables, and it is similar to the ”No
Gap” algorithm by MacEachern and Muller (1998) when the number of auxiliary clusters is
set to one. This algorithm is probably the most efficient one for nonconjugate cases. The
widely used R package “DPPackage”, for example, uses this algorithm as the default one. I
implement this algorithm in C++ for the posterior simulation of the Roy-Type DPM model.
The conditional sampler works directly with G, and does not integrate out the mixing weights.
Ishwaran and James (2001) present a conditional sampler – or blocked sampler – based on the stick-
breaking presentation, and Ishwaran and James (2002) spell out the details of the algorithm of the
blocked sampler. Since the blocked sampler does not integrate out the infinite-dimensional G, the
issue for conjugacy does not apply for this type of sampler. However, the blocked sampler is based
on an approximation of DP – a truncated DP, and it works with a finite version of the stick-breaking
process as illustrated in section (3.2.1). To address the concern of truncation, Papaspiliopoulos and
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Roberts (2008) propose a retrospective sampler that does not need truncation while keeping the
desirable features of the blocked sampler. Separately, Walker (2007) gives a slice sampler for DPM
models, addressing the same issue of truncation.
In the field of linear IV models, Conley et al. (2008) use DPM to model the joint distribution of
the error terms from structural and selection equations. They show that the resulting semiparametric
Bayesian estimator is more precise when compared to Bayesian estimators with normal prior, or to
frequentist estimators such as Two-Stage Least Square (TSLS) and Limited Information Maximum
Likelihood (LIML) estimators. Particularly, the DP estimator is found to excel in efficiency when
the errors are log-normal or the instruments are not strong.
In the area of treatment effects estimation, Chib and Hamilton (2002) propose a semiparametric
DPM with Roy-type selection. The joint distribution of the three error terms is specified as follows:
UiD
Ui1
Ui0
 ∼
0, λ
−1
i

1 σ1D σ0D
σ1D σ
2
1 σ10
σ0D σ10 σ
2
0


where
λi ∼ G
G | G0 ∼ DP (αG0)
G0 | Gamma(v/2, v/2)
Here the DP prior is placed on the scale parameter of the joint distribution of the error terms. This
model appears to be tractable and gives reasonable results for their chosen application of estimating
the wage premium associated with union membership. However, since the DP prior is only placed
on the scale parameter, the heterogeneity that is captured by this model specification can be quite
limited.
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In marketing, Burda et al. (2008) apply a DP prior on key parameters such as price elasticity in a
discrete choice model. Their DPM is able to identify a complex multi-modal preference distribution,
and provide useful insights into consumers’ shopping behavior.
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4 Modeling Heterogeneity in Treatment Effects: A Two-Equation DPM
Selection Model
4.1 Model Specification
Consider a canonical linear model for estimating treatment effects that allows for possible endo-
geneity:
X∗i = Z
′
iδ + ηi
Yi = Xiβi +W ′iγi + ξi
(4.1)
Here Yi, Xi,Wi andZi are observable variables fromN independent individuals (i = 1, · · · , N).
Yi is the dependent variable of our interest, and Xi is the binary variable indicating the status of
treatment: Xi = 1 if the individual is in the treatment group, and Xi = 0 for those in the control
group.
The selection model is specified as a Probit, same as in MT2010. The latent variable X∗i is
interpreted as the utility obtained from the treatment, and
Xi =

1 if X∗i >= 0
0 if X∗i < 0
Wi are exogenous covariates. Zi are the instruments that include all the variables in Wi.
The usual way of modeling the endogeneity is to assume a bivariate normal distribution of ηi
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and ξi:  ξi
ηi
 ∼
0,
 σ11 σ12
σ12 σ22


An alternative – and often computationally simpler – way of handling endogeneity is to reparame-
terize ξi as a linear function of ηi (Geweke, Gowrisankaran, and Robert, 2003):
ξi = ρiηi + εi (4.2)
where the covariance of ηi and εi, cov(ηi, εi), is assumed to be 0. Plugging equation (4.2) into
equation (4.1) we have:
X∗i = Z
′
iδ + ηi
Yi = Xiβi +W ′iγi + ρiηi + εi
(4.3)
ηi is assumed to be from normal distribution:
ηi ∼ N(0, 1)
Since we do not observe X∗, we normalize the variance of ηi to be 1 for identification. εi is also
assumed to be from a normal distribution:
εi ∼ N(µi, σ2i )
Note here the subscript i on β, γ, µ and σ2 indicates that they are random effects parameters:
Coefficients of different individuals can be drawn from different distributions. If panel data are
available, this setup naturally leads to a hierarchical model in Bayesian inference. In the case of
cross sectional data, some form of clustering is needed to be able to estimate individual parameters,
resulting in a mixture model.
Denote θi = (βi, γi, ρi, µi, σ2i ), and augment the data with indicators si:
θi = θk if and only if si = k(k = 1, · · · ,K)
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Here K is the number of components, or latent classes. We can rewrite (4.3) conditional on the
indicators:
X∗i = Z
′
iδ + ηi
Yi | si = Xiβsi +W ′iγsi + ρsiηi + εi
(4.4)
and
εi | si ∼ N(µsi , σ2si)
Denote the probability that one individual belongs to kth component as pk, where k = 1, · · · ,K.
The vector of probability is denoted as P = (p1, · · · , pK). If we assume the indicators si are
drawn from the multinomial distribution given the prior P , and P is from the conjugate Dirichlet
distribution:
si | P ∼Mutli(p1, · · · , pK)
P ∼ Dirichlet(α/K, · · · , α/K)
(4.5)
then this setup results in the commonly used FMM model if K is finite. Note this setup is different
from MT2010 and Geweke and Keane (2007) in that no covariates are used to model explicitly the
probability of one individual belonging to some latent class.
Interesting enough, Neal (2000) shows that whenK goes to infinity this setup leads to a Dirichlet
Process Mixture model (DPM), with α as the precision parameter of the Dirichlet Process. This
connection demonstrates that DPM can well be an alternative to FMM, especially when we do not
have good information on the probable number of components in the data.
In (4.4) a DP prior is put on all parameters of the structural equation. But in many situations it is
appropriate to put a DP prior only on some parameters. There are a few benefits of this selectiveness.
For one thing, the posterior simulation of DPM is computationally intensive, and if we know a priori
that some parameters are indeed from the same distribution, we can save some computation time
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by not using a DP prior on them. A more important concern is that the base distribution of a DP
prior, G0, has to be informative. And as the dimension of a DP prior goes up, it will become more
difficult to find an appropriate prior for the base distribution. A third reason is that DPM is known
to have difficulties dealing with not-well-separated components, thus it is necessary to reduce the
dimensionality of a DP prior when appropriate (see Green and Richardson (2001) for a detailed
discussion).
Formally the DPM is specified as follows:
X∗i = Z
′
iδ + ηi
Yi = U ′iψ + V
′
i φi + εi
(4.6)
where
εi ∼ N(0, σ2i )
Note a DP prior is put on φi and εi, but not on ψ.
For the reasons mentioned above, I start with a model of putting a DP prior only on the error term
of the structure equation. Progressively, a DP prior is placed on more parameters. This progression
leads to four models as follows:
• U = (X,W, η), V = 1ι. A DP prior is only placed on the error term. This scenario is referred
to as Error in the model selection section.
• U = (X,W ), V = (1ι, η). A DP prior is placed on the error term and the covariance term.
This scenario is referred to as Rho.
• U = W,V = (1ι,X, η). A DP prior is placed on the error term, covariance term and the
coefficient of the endogenous treatment variable. This scenario is referred to as Both.
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• U is an empty set, and V = (1ι,X, η,W ). A DP prior is placed on all parameters of structural
equation. This scenario is referred to as Mixed.
4.2 MCMC Algorithm
Denote θi = {φi, σi}, Y˜i = Yi−U ′iψ = V ′i φi + εi, ∆i = (Ui, V i, Zi, ψ). The estimation algorithm
progresses in two steps:
1. Conditional on θi draw δ and ψ.
2. Conditional on δ and ψ, calculate Y˜i, and draw θi taking Y˜i as “Data”.
Step 1 can be implemented with a Gibbs sampler after we augment the data with latent variable X∗;
step 2 is implemented with a marginal DP sampler taking Y˜ as given.
The joint density of observed data and latent data for the ith individual, conditional on θi, thus
Y˜i , is as follows:
f(X∗i , Xi, Yi|Y˜i,∆i) = p(X∗i |Y˜i,∆i)
×p(Xi|X∗i , Y˜i,∆i)
×p(Yi|Xi, X∗i , Y˜i,∆i)
For the purpose for model exposition, η is separated from either U or V . Denote U−i , V
−
i ,φ
−
i ,
and ψ− as follows:
Ui = (U−i , ηi), ψ = (ψ
−, ρ)
Vi = (V −i , ηi), φi = (φ
−
i , ρi)
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If a DP prior is used on the ρi, then the likelihood is as follows:
f(X∗i , Xi, Yi|Y˜i,∆i) =
exp
(
−0.5 (X∗i − Ziδ)2
)
√
2pi
[
XiI{X∗i >0} + (1−Xi) I{X∗i <0}
]
×
exp(−0.5σ−2i (Yi − Uiψ − V −i φ−i − ρi (X∗i − Ziδ))2√
2piσ2i

otherwise:
f(X∗i , Xi, Yi|Y˜i,∆i) =
exp
(
−0.5 (X∗i − Ziδ)2
)
√
2pi
[
XiI{X∗i >0} + (1−Xi) I{X∗i <0}
]
×
exp(−0.5σ−2i (Yi − U−iψ− − Viφi − ρ (X∗i − Ziδ))2√
2piσ2i

The priors are specified as follows:
φi | G iid∼ G
G ∼ DP (αG0)
G0 ≡MVN(φ,H−1φ |h)Gamma(a, b)
φ ∼MVN(φ,H−1
φ
)
ψ ∼MVN(ψ,H−1ψ )
δ ∼MVN(δ,H−1δ )
(4.7)
Priors are chosen to reflect reasonable prior information, and also for the convenience of making
draws from posterior. The priors on ψ and δ are chosen to be diffuse normal prior for convenience
since they will be dominated by the data in any case. The parameters of the DP prior on φ , however,
deserve more careful thinking. The baseline distribution G0 is specified as a conjugate Normal-
Gamma distribution to allow for convenience of computing the marginal density of the data which
is required in the DP algorithm, as well as that of drawing new values in the “Remix” step. When
choosing the hyper parameters, we let them be as diffuse as possible, but at the same time some
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support is given for the variance to exclude absurd choices of mean parameters. Specifically, the
hyper parameters are specified as follows:
• Hφ: The precision matrix is a diagonal matrix. That is, a priori, the parameters in φ vector
are independent. For each parameter, the prior variance is 16 times of the OLS variance.
• φ: This is an all-zero vector.
• H
φ
: This is a diffuse diagonal matrix with 0.01 for each diagonal value.
• a: This is the shape parameter of the Gamma distribution for G0, fixed at 1.
• b: This is the rate parameter of the Gamma distribution for G0, fixed at 2.
• ψ: This is an all-zero vector.
• Hψ: This is a diffuse diagonal matrix with 0.01 for each diagonal value.
• δ: This is an all-zero vector.
• Hδ: This is a diffuse diagonal matrix with 0.01 for each diagonal value.
• aα: This is the shape parameter of the Gamma distribution for the DP precision parameter α,
fixed at 1.
• bα: This is the rate parameter of the Gamma distribution for the DP precision parameter α,
fixed at 1.
Given the priors specified above, the Gibbs sampler is as follows:
1. The latent vectors X∗i (i = 1, ...N) are conditionally independent with normal distribution
X∗i
iid∼ N
[
X
∗
i , Hi
−1]
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where
Hi = 1 + ρ2iσ
−2
i ,
X
∗
i = Ziδ +Hi
−1
ρiσ
−2
i (Yi − Uiψ − Y˜i)
Each variable is truncated such that
X∗i > 0 if Xi = 1 and X∗i < 0 if Xi = 0.
2. The full conditional distribution of δ is δ ∼ N [δ,H−1δ ] where
Hδ = Hδ +
N∑
i=1
Z ′i(1 + ρ
2
iσ
−2
i )Zi
δ = H−1δ [Hδδ +
N∑
i=1
{Z ′i(1 + ρ2iσ−2i ))X∗i
−Z ′iρiσ−2i (Yi − Uiψ − Y˜i)}].
3. The full conditional distribution of ψ is ψ ∼ N
[
ψ,H
−1
ψ
]
where
Hψ = Hψ +
N∑
i=1
U ′iσ
−2Ui
ψ = H−1ψ [Hψψ +
N∑
i=1
U ′iσ
−2(Yi − Y˜i)]
4. Based on the Polya Urn representation of the Dirichlet Process, we draw θi conditional on
θ−i (The conditioning on ψi and δi is assumed here since we take Y˜i as “data”), where θ−i is
all the θ except the ith.
(a) Calculate the marginal densities of data after we observe the ith individual. The marginal
density is just the product of normalizing constants of likelihood (Univariate normal
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distribution) and prior(Normal-Gamma distribution), divided by the normalizing con-
stant of the posterior, which is also a Normal-Gamma distribution due to the conjugacy.
Specifically,
P (Y˜i) =
∫
p(Y˜i|θi)G0(θi|λ)dθi
=
∫
N(Y˜i|φ,H−1φ )MVN(φ,H−1φ |h)Gamma(a, b)dφdh
=
∫ √
h√
2pi
exp(−h
2
(Y˜i − φVi)2) 1√
2pi
ba
√
Det(H)
Γa
ha−
1
2 exp(−bh)
exp(−h
2
(φ− φ)′H(φ− φ))dφdh
=
√
h√
2pi
1√
2pi
ba
√
Det(H)
Γa
∫
exp(−h
2
(Y˜i − φVi)2)ha− 12 exp(−bh)
exp(−h
2
(φ− φ)′H(φ− φ))dφdh
=
√
h√
2pi
1√
2pi
ba
√
Det(H)
Γa
∫
ha−
1
2 exp(−bh)exp(−h
2
(φ− φ)′H(φ− φ))dφdh
=
√
h√
2pi
1√
2pi
ba
√
Det(H)
Γa
( b
a
√
Det(H)
Γa )
−1
∫
(
b
a
√
Det(H)
Γa
)ha−
1
2 exp(−bh)
exp(−h
2
(φ− φ)′H(φ− φ))dφdh
=
√
h√
2pi
1√
2pi
ba
√
Det(H)
Γa
( b
a
√
Det(H)
Γa )
−1
where
H = H + V ′i Vi
φ = φ+ V ′i Y˜i
a = a+ 0.5
b = b+ 0.5 ∗ (φ′Hφ+ Y˜i2 + φ′Hφ)
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(b) Calculate the probabilities for the multinomial draw for θi
q0 =
α
α+ (N − 1)
∫
p(Y˜i|θi)G0(θi|λ)dθi if k = i
qk =
1
α+ (N − 1)p(Y˜i|θk) for k = (1, . . . , i− 1, i+ 1, . . . , N)
Normalize the probabilities:
q∗0 =
q0
q0 +
∑N−1
k=1 qk
q∗k =
qk
q0 +
∑N−1
k=1 qk
(c) With probability of q∗k, set θi as θk, one of the existing clusters; with probability of
q∗0 draw a new θ from the one observation posterior distribution of θi, creating a new
cluster.
(d) Perform the “Remix” step. Denote θ∗j as unique values of θi, where j = 1, . . . ,K
and K is the number of clusters. For each θ∗j redraw it from the posterior distributions
after observing all the individuals in this cluster. The posterior distribution is from a
Normal-Gamma distribution with the following parameters:
H = H + V ′jVj
φ = φ+ V ′j Y˜j
a = a+ 0.5 ∗Nj
b = b+ 0.5 ∗ (φ′Hφ+ Y˜j ′Y˜j + φ′Hφ)
where Nj is the number of observations that fall into the jth cluster. We first draw a
new precision parameter:
hj ∼ Gamma(a, b)
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then conditional on the newly drawn h we draw the new φj :
φj ∼ N(φ, 1
hjH
)
(e) Draw the precision parameter of DP α . Escobar and West (1998) shows that, with
a Gamma prior Gamma(aα, bα) on α and data augmentation, the posterior of α is a
mixture of two Gamma distributions:
i. Conditional on the current value of α, draw the auxiliary variable ζ:
ζ ∼ Beta(α+ 1, N)
where N is the number of observations.
ii. Calculate the weights for the two Gamma distributions:
piζ =
(aα + I∗ − 1)/(N ∗ (bα − log(ζ))
1 + (aα + I∗ − 1)/(N ∗ (bα − log(ζ))
where I∗ is the number of components
iii. Draw a new α from the following mixture of two Gamma distributions:
α ∼ piζGamma(aα+I∗, bα−log(ζ))+(1−piζ)Gamma(aα+I∗−1, bα−log(ζ))
(f) Draw θN+1. For each iteration the MCMC algorithm generates a set of θis, and often
we are more interested in the mixture distribution of θ :
p(θN+1|Data) =
∫
p(θN+1|Θ)p(Θ|data)dΘ
Since we have I∗ unique θis for each iteration, we can easily draw θN+1 with the fol-
lowing probability:
i. With probability αα+N draw a new value from the base distribution G0.
ii. With probability 1α+N take the θi that is associated with the ith individual.
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4.3 Application
4.3.1 Data Set: Medicare Current Beneficiary Survey
The data used in this application is closely related to the one used in MT2010. The main difference
is that we only use observations for seniors who have purchased Medigap plans. The data come
from 2003-05 Medicare Current Beneficiary Survey (MCBS).
MCBS provides information on demographics (age, gender, race, education level, family in-
come, marital status, and children), socioeconomics (e.g. income), and an extensive list of health
status variables (including chronic conditions, disability, and activity limitations). The “Cost and
Use” file provides information on Medicare utilization such as expenditures. MCBS also contains
information on supplemental insurance, source of the plan, the premium paid, and coverage of
prescription drug expenses, of which some plan attribute information can serve as instrumental
variables for modeling plan choice.
A few notes are in order on how the sample is constructed from MCBS data:
• This sample does not include enrollees with Medicaid or other public plans as well as those
who hold more than one health plan or who switch plans during the year.
• Due to the panel structure of the data, we have multi-year observations on some individuals.
As this is a cross-sectional study, only one observation per individual is retained in sample –
following the convention of using the first time the individual is sampled.
• Since 93% of this sample has positive expenditures, I avoid the two-part hurdle structure and
focus on the conditional model of positive expenditures.
• As the result of trimming, the final sample contains 2,309 observations from 3 years, the
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breakdown being 1,055 from 2003, 642 from 2004, and 612 from 2005.
4.3.2 Description of Variables in the Model
The logarithm of total drug expenditure, LNAAMTTOT, is the dependent variable and drug cover-
age (COVRX) is the binary endogenous treatment variable. See Table (1) for the full list of variables
used in the model.
The covariates consist of six blocks of variables:
• Self-reported health status: VEGOOD, GOOD, FAIR and POOR. EXCELENT is the baseline
dummy that is not included in the model.
• Indicators for heart and other chronic conditions: HEARTCOND and OTHCOND.
• Indicators of present and past smoking habits: SMOKNOW and SMOKEVER.
• Geographic dummies: NOREAST, WEST, SOUTH and MSA. The excluded region indicator
is Middle West.
• Socioeconomic status: AGE, WHITE, MALE, MARRY, WIDOW, LVALONE, DEGRCV,
number of children living CHNLNM, employment status JOBSTAT, and, the natural loga-
rithm of income LNINCOME.
• Two year dummies: YEAR2004 and YEAR2005. YEAR2003 is the excluded baseline level.
In order to identify the endogenous key parameter, and thus separate the treatment effects from
selection effects, one needs to have a good instrumental variable. In this dataset the monthly pre-
mium, MOAMT, serves as the IV. As the first check the correlation and scatter plot between COVRX
and MOAMT show that there is a quite strong correlation between premiums and health insurance
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choices. This positive correlation makes intuitive sense: The sample used in this study only in-
cludes Medigap enrollees, and those seniors choose to pay higher premiums to have prescription
drug coverage. Therefore MOAMT could potentially be a strong instrument.
The harder argument is to prove that the instrument is a valid one, which is something we will
never be able to do with certainty. “One can only subject candidate instruments to intuitive, em-
pirical, and theoretical scrutiny to reduce the risk of using invalid instruments.” (Murray, 2006).
The main rationale behind this choice is that since the premium is a sunk cost after the purchase
of the insurance plan, it should not, in theory, have an impact on health-care utilization. Thus the
assumption that the premium only affects drug expenditure through plan attributes is reasonable, as
a higher premium does not necessarily translate into better drug coverage. Also, we find that current
drug expenditure, after controlling the covariates, has little relationship to the premium paid. The
residual partial correlation between premium and drug expenditure is indeed quite small. Hence,
MOAMT appears to be a suitable instrument.
As mentioned in the introduction, in order to interpret the IV estimate as a valid treatment effect,
we need to look at the relationship between propensity score and the instrumental variable. If the
IV is a monotonic transformation of the propensity score, then we will have the confidence to state
that the IV estimate indeed identifies the treatment effect we plan to estimate.
The propensity score is estimated using a boosted logistic regression. I plot the instrument
variable with the propensity score in Figure (1), and we can see that the monotonicity condition
roughly holds for almost the entire region.
40
4.3.3 Sample Summary Statistics
The summary statistics, broken down by the insurance status COVRX, are provided in Table (1).
Figure (2) is the kernel density plot of the dependent variable. It is quite clear that the distribution
is not normal and shows substantial skewness in the left tail.
Even though the differences in the means for many variables in Table (1) are not substantial
for the two groups, the difference for the dependent variable is very large – the difference of the
logarithm of drug expenditure is 0.23, and in the dollar terms it is $337. A similar difference is
noted in the levels of income.
To get a better gauge of the differences between treatment and control groups, two estimates of
differences for all the covariates are reported here. One is the traditional t-statistic:
∆X =
X1 −X0√
S20/N0 + S
2
1/N1
where S20 and S
2
1 are the sample variances of X in the treatment and control group. Another one is
the differences in averages scaled by the sum of variances:
∆X =
X1 −X0√
S20 + S
2
1
Imbens and Wooldridge (2009) argue that the latter provides a better measure of the differences.
The reasoning for their preference for the latter is as follows: A larger sample size does not nec-
essarily make the imbalance between the two subsamples bigger, but a larger sample will lead to
higher t-statistics, which artificially amplifies the differences. The normalized difference, however,
does not change with sample size systematically, thus providing a more reasonable measure of the
difference between the subsamples.
As a rule of thumb, the linear regression method, which assumes the control group and treatment
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are similar, could be problematic if the scaled difference in mean is greater than one quarter (Imbens
and Wooldridge, 2009). Table (2) shows the results of these two estimates. Measured by the nor-
malized differences in means, only the instrumental variable MOMAT and year dummy YEAR2005
are quite different between these two groups, thus the imbalance is not a big concern in this sample.
4.3.4 Model Selection and Fit
Table (4) lists the marginal likelihood values calculated by Importance Sampling (IS), Reciprocal
Importance Sampling (RI) and Bridge Sampling (BS) methods. From the table we can see the BS
estimator gives the most stable results. The model where a DP prior is put on all the parameters of
the expenditure equation appears to be the best model, thus I report the model fit and results for that
model only.
One of the objectives of this model is to improve the model fit of MT2010. Figure (3) shows that
this DPM model predicts quite well in both tails. Instead of lumping relatively healthy individuals all
into one group, DPM is able to devote many components to those individuals, leading to substantial
improvement of the model fit in the tails.
4.3.5 Estimation Results
A common feature of mixture models with latent variables, especially when endogeneity is also
modeled, is that the MCMC chain often shows a high degree of autocorrelation for parameters on
the endogenous variable and covariance term. As a result, it often takes a very large number of
iterations for the chain to converge.
The MCMC algorithm produced well-mixed posterior draws and the chain appears to have con-
verged rather quickly. Figure (4) plots the autocorrelation for the key parameters of interest. They
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show little autocorrelation, if at all.
The posterior distribution of the intercept clearly shows bi-modality, and that of the variance
term and covariance show strong skewness. The parameter on the endogenous variable COVRX,
however, is somewhat unimodal. Figure (5) plots the posterior draws for the key parameters of
interest and all of them appear to mix well.
The estimation results from the Mixed model are reported in this section. Table (5) shows the
posterior means and standard deviations, as well as the p-values, for all the parameters of the se-
lection equation. With increasing age, people in our sample are less likely to have drug coverage.
Also, whites, males, the married and the widowed are less likely to have it. Living in a metropolitan
statistical area, on the other hand, increases the chance of having drug coverage. HEARTCOND and
OTHCOND positively affect the coverage probability, as well as all the health statuses: VEGOOD,
GOOD, FAIR, and POOR – this makes sense since EXCELLLENT status is the baseline. Surpris-
ingly, more education does not lead to higher drug coverage, but it is not statistically significant.
There is a positive relationship between income and drug coverage, but again it is not statistically
significant. Smoking history has virtually no effect on drug coverage, while current smokers are
less likely to have coverage. Being employed decreases the probability of coverage, which on the
surface seems to go against common sense. However, since this sample only includes those who
are enrolled into Medigap plans where prescription drug coverage is optional, those employed very
likely already have drug coverage from their employers, and thus would not need additional cover-
age from Medigap plans.
Table (6) shows the results for the expenditure equation. 1 Since we report the aggregate results
1Table (3) lists the estimates from different estimators. The estimate from Roy-type Model with Normal Errors is
calculated according to Heckman et al. (2001); All the rest are directly from the respective coefficient on the endogenous
treatment variable.
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without decomposing the sample into different components, the standard deviations in general are
quite high, resulting in many parameters on the expenditure equations not being statistically signifi-
cant. Still we can see that coefficients on the intercept and the endogenous variable, as well as most
health related variables, are significant.
We do not attempt to identify different components under DPM, nonetheless we are able to detect
some patterns of clustering from the posterior draws. The posterior distribution of the intercept term
is clearly bi-modal, and if we plot the draws of the parameter on the intercept against those of the
key parameters, we can see two discernible clusters. The one with higher average expenditure,
which could be interpreted as the relatively unhealthy group, appears to be a tighter cluster in those
plots, while the one with lower average expenditure demonstrates much more heterogeneity.
Figure (6), (7), and (8) are the scatter plots of the posterior draws of coefficients on the intercept
and the variance, the intercept and the endogenous variable COVRX, and the intercept and the
covariance term, respectively.
4.3.6 Calculation and Interpretation of Treatment Effects
As part of the MCMC algorithm, the treatment effect (TE) and the treatment effect for the treated
(TT) are calculated for each individual.
For each iteration after burn-in, they are calculated as follows:
TEi = exp
(
Wiγ + 0.5
(
ρ2i + σ
2
i
))
[exp (βi)− 1] . (4.8)
TTi =
Φ (Ziδ + ρi)
Φ (Ziδ)
exp
(
Wiγ + 0.5
(
ρ2i + σ
2
i
))
[exp (βi)− 1] . (4.9)
where r stands for the rth draw from the posterior, and i denotes the ith individual. The average
treatment effect (ATE) and average treatment effect on the treated (ATT) are then calculated for
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each draw:
ATEr =
1
N
N∑
i=1
TEri
ATT r =
1
N1
N1∑
i=1
TT ri
where N is the full sample size, and N1 is the sample size of the treatment group.
The posterior mean of ATE is estimated to be $1, 132, and that of ATT is $858. The density
plots of TE and TT are shown in Figure (9) and (10). Clearly they show substantial heterogeneity
in treatment effects across individuals. Figure (11) shows the jitter plot of TT and HEARTCOND
and Figure (12) shows the jitter plot of TT and OTHCOND. For better illustration, I use jitter plots
instead of scatter plots to avoid the superimposition of data points, since both HEARTCOND and
OTHCOND are binary variables. We can see from these plots that the treatment effects are higher
for those who have either the heart condition or other chronic conditions.
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5 Modeling Heterogeneity in Treatment Effects: A Roy-type DPM
Model
5.1 Model Specification
I first present a variant of the Roy-type model without the DPM part. For brevity I suppress the
subscripts for each individual before introducing the DPM into the model. The three-equation Roy-
type model is formally defined as follows:
Y1 = Xβ1 + U1 (5.1)
Y0 = Xβ0 + U0 (5.2)
D∗ = Zδ + UD (5.3)
where Y1 denotes the outcome with treatment and Y0 the outcome without treatment. U0 and U1 are
the error terms for each outcome equation. D∗ is the latent utility of receiving treatment, UD is the
unobserved utility, and Z is the instrument.
Denote D as the binary treatment variable. Define D = 1 if the individual is in the treatment
group, and D = 0 if not. The latent utility D∗ determines the treatment decision based on the
following rule:
D(Z) = I(D∗ > 0) = I(Zδ + UD > 0)
where I(A) is the indicator function that takes the value 1 if the event A is true. The realized
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outcome Y is defined as:
Y =

Y0 if D = 0
Y1 if D = 1
The usual way of modeling the endogeneity is to assume a trivariate normal distribution for the
three error terms, with the variance of UD normalized to 1 for identification:
UD
U1
U0
 ∼
0,

1 σ1D σ0D
σ1D σ
2
1 σ10
σ0D σ10 σ
2
0


However one difficulty with this parametrization is to draw from the posterior distribution of the
covariance matrix – we can not draw directly from the conjugate Wishart distribution with UD
normalized to 1. To get around this issue, I follow Koop and Poirier (1997) to rewrite the joint
distribution above as the product of a conditional and a marginal distribution:
P (U0, U1, UD) = P (U0, U1|UD)P (UD)
Since we only observe either Y0 or Y1, but never both of them at the same time, the correlation term
between them, σ10, does not enter the likelihood and therefore is unidentified. One way of dealing
with unidentified parameters is to not update them in the MCMC algorithms; thus we can fix them
at specific values for computational convenience. Specifically I follow Deb, Munkin, and Trivedi
(2006) to directly include the unobserved utility UD into the conditional means of Y0 and Y1:
Y1 = Xβ1 + ρ1UD + ε1 (5.4)
Y0 = Xβ0 + ρ0UD + ε0 (5.5)
where cov(UD, ε0|X) = 0, cov(UD, ε1|X) = 0, and ε0 ∼ N(0, σ20), ε1 ∼ N(0, σ21), and UD ∼
N(0, 1). With this parametrization, we can simply fix σ10 at 0 and not update it in the MCMC
47
algorithm. The endogeneity under this setup is modeled by controlling the unobserved heterogeneity
in the two regression equations, and the remaining parts of Y0 and Y1, ε0 and ε1, are therefore
assumed to be independent of the treatment.
Now rewrite (5.4) and (5.5) with subscripts for individuals and outcomes (The subscript D on
UD is dropped for notational simplicity):
D∗i = Ziδ + Ui (5.6)
Yij = Xijβij + ρijUi + εij (5.7)
where
εij ∼ N(0, σ2ij)
and i = 1, · · · , N for N independent individuals, j = 0, 1 for the two outcomes.
Note here the subscript i on β, ρ and σ2 indicates that they are random effect parameters: coeffi-
cients of different individuals can be drawn from different distributions. If panel data are available,
this setup naturally leads to a hierarchical model in Bayesian inference. In the case of cross section
data, some form of clustering is needed to be able to estimate individual parameters, resulting in a
mixture model.
To illustrate the mixture model, denote θij = (βij , ρij , σ2ij), and augment the data with indicators
sij :
θij = θkj if and only if sij = kj(kj = 1, · · · ,Kj)
where Kj is the number of components, or latent classes, for the jth outcome. We can rewrite (5.7)
conditional on the indicators:
Yij | sij = Xijβsij + ρsijUi + εij (5.8)
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where
εij | sij ∼ N(0, σ2sij )
Omitting the subscript j for the moment since it applies equally to each outcome, let pk denote
the probability that an individual belongs to the kth component, where k = 1, · · · ,K. The vector
of probabilities is denoted as P = (p1, · · · , pK). If we assume the indicators si are drawn from the
multinomial distribution given the prior P , and P is from the conjugate Dirichlet distribution:
si | P ∼Mutli(p1, · · · , pK)
P ∼ Dirichlet(α/K, · · · , α/K)
(5.9)
then this setup results in the commonly used FMM model if K is finite.
Interesting enough, Neal (2000) shows that when K goes to infinity this setup leads to a Dirich-
let Process Mixture model (DPM), with α as the precision parameter of the corresponding Dirichlet
Process. This connection demonstrates that DPM can well be an alternative to FMM, especially
when we do not have good information on the probable number of components in the data. There-
fore, we specify separate DP priors on θi0 and θi1, resulting in rather flexible DPM models for each
outcome.
5.2 MCMC Algorithm
The estimation algorithm progresses in three steps:
1. Conditional on θi0 and θi1, draw D∗i and δ.
2. Conditional on D∗i and δ, draw θi0.
3. Conditional on D∗i and δ, draw θi1.
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The step 1 can be implemented with a Gibbs sampler after we augment the data with the latent
variable D∗i ; step 2 and 3 are implemented with a marginal DP sampler.
Denote ∆ij = (Xi, Zi, δ, θij) The joint density of the observed data and the latent variable for
the ith individual, conditional on ∆ij , is as follows:
f(D∗i , Di, Yi0, Yi1|∆i0,∆i1) =
exp
(
−0.5 (D∗i − Ziδ)2
)
√
2pi
×
[
DiI{D∗i>0} + (1−Di) I{D∗i<0}
]
×
[
(1−Di)exp(−0.5σ
−2
i0 (Yi0 −Xiβi0 − ρi0(D∗i − Ziδ))2)√
2piσ2i0
+Di
exp(−0.5σ−2i1 (Yi1 −Xiβi1 − ρi1(D∗i − Ziδ))2)√
2piσ2i1
]
The priors are given as follows:
θij | G iid∼ Gj
Gj ∼ DP (αG0)
G0 ≡MNV (β,H−1β )Gamma(a, b)
β ∼MVN(β,H−1
β
)
δ ∼MVN(δ,H−1δ )
(5.10)
Priors are chosen to reflect reasonable prior information, and also for the convenience of making
draws from the posterior distribution. The priors on δ are chosen to be diffuse normal priors for
convenience since they will be dominated by the data in any case. The parameters of the DP prior
on β , however, deserve more careful thinking. The baseline distribution G0 is specified as a semi-
conjugate Normal-Gamma distribution. For choosing the hyper parameters, I let them to be as
diffuse as possible, but at the same time some support is given for the variance to exclude absurd
choices of mean parameters. Specifically, the hyper parameters are specified as follows:
50
• Hβ: The precision matrix is a diagonal matrix. That is, a priori, the parameters in β vector
are independent. For each parameter, the prior variance is 30 times of the variance obtained
from Heckman’s two-step estimator.
• β: This is an all-zero vector.
• H
β
: This is a diffuse diagonal matrix with 0.01 for each diagonal value.
• a: This is the shape parameter of the Gamma distribution for G0, fixed at 1.
• b: This is the rate parameter of the Gamma distribution for G0, fixed at 2.
• δ: This is an all-zero vector.
• Hδ: This is a diffuse diagonal matrix with 0.01 for each diagonal value.
• aα: This is the shape parameter of the Gamma distribution for the DP precision parameter α,
fixed at 1.
• bα: This is the rate parameter of the Gamma distribution for the DP precision parameter α,
fixed at 1.
Given the priors specified above, the Gibbs sampler is as follows:
1. The latent vectors D∗i (i = 1, ...N) are conditionally independent with normal distribution:
D∗i
iid∼ N
[
D∗i, Hi
−1] where
Hi = 1 + (1−Di)ρ2i0σ−2i0 , +Diρ2i1σ−2i1 ,
D∗i = Ziδ + (1−Di)Hi0−1ρi0σ−2i0 (Yi0 −Xi0βi0) +DiHi1
−1
ρi1σ
−2
i1 (Yi1 −Xi1βi1)
Each variable is truncated such that
D∗i > 0 if Di = 1 and D∗i < 0 if Di = 0.
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2. The full conditional distribution of δ is δ ∼ N [δ,H−1δ ] where
Hδ = Hδ +
N∑
i=1
Z ′i(1 + (1−Di)ρ2i0σ−2i0 +Diρ2i1σ−2i1 )Zi
δ = H−1δ [Hδδ +
N∑
i=1
{Z ′i(1 + (1−Di)ρ2i0σ−2i0 +Diρ2i1σ−2i1 ))D∗i
−Z ′i((1−Di)ρi0σ−2i0 (Yi0 −Xi0βi0) +Diρi1σ−2i1 (Yi1 −Xi1βi1)}].
3. Since the DP prior is separate for each outcome, I suppress the outcome subscript j in the
exposition of the DP part of the model. Based on the Polya Urn representation of the Dirichlet
Process, we draw θi conditional on θ−i (the conditioning on D∗i and δi is assumed here),
where θ−i are all the θs except the ith one. The algorithm #8 provided in Neal (2000) is used
to draw θi, with the number of auxiliary slot, m, as 3.
(a) Create m auxiliary clusters. For the ith individual, denote K as the number of distinct
clusters among all the θs, and K− as the number of distinct clusters without counting
the ith individual itself. If K is equal to K−, i.e., the ith individual is not associated
with a singleton cluster, then create m new clusters by drawing from the baseline distri-
bution G0. Otherwise designate the singleton cluster associated with the ith individual
as the first auxiliary cluster, and create m−1 new clusters by drawing from the baseline
distribution.
(b) Rearrange the clusters so that the first K− ones are the existing clusters, and last m are
the auxiliary ones.
(c) Calculate the density of Yi at each cluster φ(Yi, θk), where θks are the unique values for
the clusters, k = 1, . . . ,K− +m.
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(d) Assign the ith individual to a new cluster, k, based on the following multinomial draw:
P (si = k|Yi, s−i, θ1, . . . , θk) =

N−i,k
N+1−αφ(Yi, θk) for 1 ≤ k ≤ K−
α/m
N+1−αφ(Yi, θk) for K
− < k ≤ K− +m
where si is the cluster indicator for the ith individual; s−i denotes all the indicators
except the ith individual; N−i,k is the number of individuals associated with the kth
cluster without counting the ith individual.
(e) Repeat the four steps above for all individuals, i = 1, . . . , N .
(f) Perform the “Remix” step. Denote θ∗k as unique values of θi, where k = 1, . . . ,K
and K is the number of clusters. For each θ∗k redraw from the posterior distribution
after observing all the individuals in the cluster. The posterior distribution is from a
semi-conjugate Normal-Gamma distribution with the following parameters:
a = a+ 0.5 ∗Nk
b = b+ 0.5 ∗ (Yk −Xkβk)′(Yk −Xkβk)
H = H + hkX ′kXk
β = H−1(Hβ + hkX ′kYk)
where Nk is the number of observations that fall into the kth cluster. A mini Gibbs
sampler is used to draw new values for hk and βk as follows:
hk ∼ Gamma(a, b)
βk ∼ N(β,H−1)
(g) Draw the precision parameter of DP α . Escobar and West (1998) show that, with a
Gamma prior Gamma(aα, bα) on α and data augmentation, the posterior of α is a
mixture of two Gamma distributions:
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i. Conditional on the current value of α, draw the auxiliary variable ζ:
ζ ∼ Beta(α+ 1, N)
where N is the number of observations.
ii. Calculate the weights for the two Gamma distributions:
piζ =
(aα + I∗ − 1)/(N ∗ (bα − log(ζ))
1 + (aα + I∗ − 1)/(N ∗ (bα − log(ζ))
where I∗ is the number of components
iii. Draw a new α from the following mixture of two Gamma distributions:
α ∼ piζGamma(aα+I∗, bα−log(ζ))+(1−piζ)Gamma(aα+I∗−1, bα−log(ζ))
(h) Draw θN+1. For each iteration the MCMC algorithm generates a set of θis, and often
we are more interested in the mixture distribution of θ :
p(θN+1|Data) =
∫
p(θN+1|Θ)p(Θ|data)dΘ
Since we have I∗ unique θis for each iteration, we can easily draw θN+1 with the fol-
lowing probability:
i. With probability αα+N draw a new value from the base distribution G0.
ii. With probability 1α+N take the θi that is associated with the ith individual.
5.3 Application
5.3.1 Data Set: Medicare Expenditure Panel Survey
The data set used in this application is constructed from the 2002-08 Medical Expenditure Panel
Survey (MEPS), the latest seven years of data that are available from the MEPS website. We are
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interested in estimating the pure incentive effects of having private medical insurance on the outpa-
tient expenditures. Here the outpatient expenditures are calculated as the total medical expenditures
minus hospital expenditures. The rationale behind this is that hospital expenditures are often of an
involuntary nature, whereas outpatient expenditures are those involved with deliberate decisions,
with the status of medical insurance expected to be part of the decision making.
MEPS provides information on demographics (age, gender, race, education level, family income,
marital status, and children), socioeconomics (e.g. income), and an extensive list of health status
variables (including chronic conditions, disability, and activity limitations). MEPS also contains
information on the status of insurance: Does one individual have any type of medical insurance
when surveyed? And if yes, what type of insurance plan: public or private.
This sample does not include any individuals enrolled in any public medical insurance plans
such as Medicare or Medicaid. I restrict our sample to those who have jobs, but are not self-
employed. For the same reason we only include individuals between 25 and 65 years of age. Due
to the panel structure of the data, we have multi-year observations for some individuals. As this
is a cross-sectional study, only one observation per individual is retained in the sample, following
the convention of using the observation when the individual is sampled for the first time. Since
more than 80% of this sample has positive expenditures, I avoid the two-part hurdle structure and
focus only on the conditional model of positive expenditures. As the result of trimming, the final
sample contains 33, 081 individuals, with the majority of them, 28, 863, having some type of private
medical insurance.
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5.3.2 Description of Variables in the Model
The logarithm of total drug expenditure, LOUTEXP, is the dependent variable and the private med-
ical insurance status (PRVEV) is the binary endogenous treatment variable. See Table (7) for the
full list of variables used in the model.
The covariates consist of four blocks of variables. Self-reported health status: VEGOOD,
GOOD, and FAIRPOOR (Either FAIR or POOR). EXCELENT is the baseline dummy that is not
included in the model. Also included in the model is the indicator for having a limitation of phys-
ical activities PHYSLIM. Geographic dummies: NOREAST, WEST, and SOUTH. The excluded
region indicator is MIDDLEWEST. MSA indicates whether the individual lives in a metropolitan
statistical area. Socioeconomic status: AGEX (age divided by 10), EDUCYR (years of education),
FAMSZEYR (family size), MALE, MARRY, BLACK, HISP (Hispanic) and INCOME (income
in thousand dollars). Six year dummies: YEAR2003 to YEAR2008. YEAR2002 is the excluded
baseline level.
In order to identify the endogenous parameter, and thus separate the treatment effects from the
selection effects, one needs to have a good instrumental variable. In this dataset the firm size,
FIRMSIZE (firm size divided by 10), serves as the IV. The first check of the correlation and scatter
plot between PRVEV and FIRMSIZE shows that there is a quite strong correlation between firm
size and health insurance choices. This positive correlation makes intuitive sense: larger firms tend
to provide employer-sponsored medical insurance plans as part of the benefits.
The harder argument is that the chosen instrument is a valid one, which is something we will
never be able to do with certainty. “One can only subject candidate instruments to intuitive, em-
pirical, and theoretical scrutiny to reduce the risk of using invalid instruments.” (Murray, 2006). In
our case, it seems reasonable to assume that the firm size should not have a direct impact on one
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individual’s medical expenditures.
5.3.3 Sample Summary Statistics
The summary statistics, broken down by the insurance status PRVEV, are provided in Table (7).
Figure (13) is the kernel density plot of the dependent variable. It is quite clear that the distribution
is not normal and shows some skewness in the left tail.
A quick look at the summary statistics reveals that the control group and the treatment group are
quite different. The treatment group is much bigger than the control group. It has 28, 862 individuals
relative to 4, 219 individuals in the control group. More importantly, the expenditures and key
covariates also differ substantially. On average those without insurance spend $1, 230 on outpatient
care, while those with insurance spend $2, 492, more than double the amount of the former. Income
level and education also indicate that they belong to different socioeconomic groups: Those with
insurance, on average, have two and a half more years of education, and their income is almost
double of those without insurance ($76, 200 vs. $39, 890).
To get a more precise gauge of the differences between the treatment and the control groups, two
estimates of differences for all the covariates are reported here. One is the traditional t-statistic:
∆X =
D1 −D0√
S20/N0 + S
2
1/N1
where S20 and S
2
1 are the sample variances of X in the treatment and control group. The other is the
differences in averages scaled by the sum of variances:
∆X =
D1 −D0√
S20 + S
2
1
Imbens and Wooldridge (2009) argue that the latter provides a better measure. The reasoning
for their preference for the latter is as follows: A larger sample size does not necessarily make the
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imbalance between the two subsamples bigger, but a larger sample will lead to higher t-statistics,
which artificially amplifies the differences. The normalized difference, however, does not change
with sample size systematically, thus providing a more reasonable measure of the difference be-
tween the subsamples.
As a rule of thumb, the linear regression method, which assumes the control group and treat-
ment are similar, could be problematic if the scaled difference in means is greater than one quarter
(Imbens and Wooldridge, 2009). Table (8) shows the results of these two estimates. The normal-
ized differences in means clearly show those two subsamples are quite different from each other,
especially in key covariates such as income, education, firm size, etc., and it is thus reasonable to
assume that individuals in those two groups would behave differently in insurance purchase deci-
sion and health care resources utilization, which in turn calls for a Roy-type model where essential
heterogeneity is explicitly modeled.
5.3.4 Model Selection and Fit
It is well known that calculating the marginal likelihood for mixture models is not a trivial task.
The Harmonic mean estimator, the easiest one to calculate since it is a natural byproduct of MCMC
algorithms, is known to be unstable for FMM. Fruhwirth-Schnatter (2006) show that, for mixture
models, sampling-based techniques are particularly effective in estimating the marginal likelihood.
The BS estimator uses both importance sampling draws as well as posterior draws in calculating the
marginal likelihood, and Fruhwirth-Schnatter (2004) shows that the variance of the BS estimator is
always bounded, thus making it a much more stable one.
Table (10) lists the marginal likelihood values calculated by Importance Sampling (IS), Recip-
rocal Importance Sampling (RI) and Bridge Sampling (BS) methods. From the table we can see the
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BS estimator gives the most stable results. We calculate the marginal likelihoods for various FMM
and DPM models. A few conclusions can be drawn from this table. If we specify a DP prior – again
a separate one for each outcome – on only the error term (labeled as error), or the error term and
the covariance term (labeled as rho ), the resulting likelihoods show that they are not nearly flexible
enough to capture the heterogeneity. This is supported by the posterior draws from the DPM model:
Most parameters, especially those in the treatment group, are multi-modal and show strong skew-
ness in one or both tails. The likelihoods show that FMM with six mixing components is the best
model, and the likelihood improves substantially each time the number of components increases by
one until it reaches six. Since the sample sizes of two groups are quite different (80% of the full
sample has medical insurance), it is logical that the treatment group has more components. There-
fore, in an ideal setting, we would like to test all the combinations of number of components for
each outcome, and a combination of five components in the control group and ten components of
the treatment group, for example, might give better model fit than the one with six components for
both groups. Apparently this approach to model selection is tedious and time-consuming, and this
is precisely where the auto-tuning mechanism of DPM can be quite helpful. Indeed, the likelihood
for the DPM model dominates that of any FMM so that it does not seem necessary to exhaust every
possible combination for FMM.
The model where a DP prior is put on all the parameters of the expenditure equation (labeled as
mixed) is clearly the best model, and thus we report the model fit and results for that model only.
Additionally, figure (14), the density plots of the predicated values, shows that this DPM model
predicts well for both the subsample and the full sample.
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5.3.5 Estimation Results
The MCMC algorithm produces well-mixed posterior draws and the chain appears to have con-
verged rather quickly. Figure (15) and (16) plot the autocorrelation for the key parameters for both
the control and treatment groups. They show little auto correlation, if at all.
Figure (17) plots the posterior draws for the key parameters of interest for the control group, and
Figure (18) plots the posterior draws for the key parameters of interest for the treatment group. We
can see from those plots that the parameters of the treatment group show much more multi-modality
and skewness. All of the parameters in both groups appear to mix well.
The estimation results from the mixed model only are reported here. Table (11) shows the pos-
terior means and standard deviations, as well as the p-values, for all the parameters of the selection
equation. All the signs of the year dummies are negative and significant, indicating people are
less likely to have medical insurance since the start of the economic recession in 2001 and 2002.
With increasing age, people in our sample are more likely to have medical insurance. Also, Blacks,
Hispanics, and males are less likely to have medical insurance. Living in a metropolitan statistical
area, on the other hand, increases the chance of having medical insurance as expected. Relatively
unhealthy people are less likely to have insurance as the signs on GOOD and FAIRPOOR are neg-
ative. The strongest indicators for having medical insurance are income, education and marital
status: People with higher income and more education, as well as married ones, are significantly
more likely to have insurance. And the chosen instrument, FIRMSIZE, is strongly correlated with
the probability of having insurance: People working for larger firms are more likely to have medical
insurance, which makes sense as larger companies usually provide employer-sponsored insurance
as part of their benefits.
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Table (12) shows the results for both groups. 2 The coefficients from both groups have the same
signs; however, the magnitudes are quite different for most relevant parameters. The intercept is
much larger for the treatment group, indicating the existence of sizable treatment effects. Magni-
tudes of the effects of health status are quite different too: Relatively unhealthy people – those with
self-reported health status as VEGOOD, GOOD, FAIR or POOR, as well as those with physical lim-
itations – spend much more on medical care if they have medical insurance. The control group is
more homogeneous than the treatment group, as it has on average 8 components vs. 17 components
in the treatment group.
While we do not attempt to identify different components under DPM, nonetheless we are able
to detect some patterns of clustering from the posterior draws. The posterior distribution of the
intercept term is clearly multi-modal, and if we plot the draws of the parameter on the intercept
against those of the key parameters, we can see many discernible clusters.
Figure (19) is the scatter plot of the posterior draws of coefficients for the intercept and the vari-
ance for the both the control and treatment group. It clearly shows that there are more components
in the treatment group with regard to variance and intercept. Figure (20) is the scatter plot of the
intercept and the covariance, and it shows some interesting patterns. In the treatment group, the
coefficient on the covariance is close to zero for different clusters, indicating the selection effects
are minimal for high spenders and low spenders. The control group, however, shows a different
pattern: The high spenders show some advantageous selection effects and the low spenders show
some adverse selection effects. Finally, figure (21) is a scatter plot of the intercept and MARRY. In
general we see married people tend to spend more on health care, however we see a tight cluster of
2Table (9) lists the estimates from different estimators. The estimates from Roy-type Model with Normal Errors and
Roy-type DPM Model are calculated according to Heckman et al. (2001); All the rest are directly from the respective
coefficient on the endogenous treatment variable.
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people who spend more on health care regardless of martial status in the treatment group.
5.3.6 Calculation and Interpretation of Treatment Effects
As part of MCMC algorithm, the treatment effect (TE) and the treatment effect for the treated (TT)
are calculated in this section for each individual. For each iteration after burn-in, they are calculated
as follows:
TEri = exp
(
Ziδ + 0.5
(
ρ22 + σ
2
2
))− exp (Ziδ + 0.5 (ρ21 + σ21)) (5.11)
TT ri =
Φ (Ziδ + ρ2)
Φ (Ziδ)
exp
(
Ziδ2 + 0.5
(
ρ22 + σ
2
2
))− Φ (Ziδ + ρ1)
Φ (Ziδ)
exp
(
Ziδ1 + 0.5
(
ρ21 + σ
2
1
))
(5.12)
where r stands for the rth draw from the posterior, and i denotes the ith individual. The average
treatment effect (ATE) and average treatment effect on the treated (ATT) are then calculated for
each draw:
ATEr =
1
N
N∑
i=1
TEri
ATT r =
1
N1
N1∑
i=1
TT ri
where N is the full sample size, and N1 is the sample size of the treatment group.
The posterior mean of ATE is estimated to be $799, and that of ATT is $764. The density plots
of TE and TT are shown in Figure (22) and (23). Clearly they show substantial heterogeneity in
treatment effects across individuals.
Figure (24) shows the scatter plot of TE and INCOME, and there is a apparent negative correla-
tion between them. One possible reason for this correlation could be that people with higher income
tend to be healthier, thus spending less on health care.
Figure (25) shows the scatter plot of TE and EDUCYR, and it tells a similar story: those with
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higher education, especially those with more than twelve years of education, are likely to be health-
ier and spend less on health care.
Figure (26) shows the scatter plot of TE and AGEX, and we see older people tend to have bigger
treatment effects – this is quite logical in that people will utilize more health care as they age, and
if they have insurance, they will be more likely to see a doctor if needed. More importantly, the
variance on the treatment effects increase with age, which again makes sense in that younger people
tend to be uniformly healthier, and as people age, some of them start to have health issues while
others maintain good health well into their 50s and 60s.
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6 Conclusion and Future Research
6.1 Conclusion
This dissertation studies the endogenous treatment effects in the presence of heterogeneous re-
sponses. I show that a Bayesian Nonparametric approach can be quite fruitful in capturing the
heterogeneity in treatment effects. When compared to an FMM approach, a DPM model captures
the heterogeneity quite well by providing more flexible functional forms and thus providing better
model fit. Rather than fixing the number of components in a mixture model, DPM allows the data
and prior knowledge to determine the number of components in the data, providing an automatic
mechanism for model selection.
I propose two DPM models in this dissertation. Built on top of a canonical linear selection model,
the first DPM model specifies a DP prior on some or all the parameters of the structural equation,
and marginal likelihoods are calculated to select the best DPM model. This model is used to study
the incentive and selection effects of having prescription drug coverage on total drug expenditures
among Medicare beneficiaries, and the posterior draws and predicted density both show this model
works quite well for that application in producing sensible results and clustering patterns.
Specifically, I find that there are strong incentive effects for seniors having drug coverage – on
average those who have drug coverage spend over one thousand dollars more than those who do
not. Also I find there are advantageous selection effects, and the selection effect is found to be more
heterogeneous than the incentive effect. Under DPM we do not label groups within the sample, but
64
nonetheless two discernible clusters can be seen in the scatter plots of posterior draws. If we accept
the generally acknowledged findings in health economics that the population consists of two groups
– the healthy and less healthy groups – with the latter being likely to consume more health care
resources, we can show that the relatively unhealthy group is much more homogeneous than the
other group. Graphically, the group with higher average expenditure is a much tighter cluster than
the one with lower average expenditure. This in fact provides evidence for utilizing a DPM model
where we can devote more components to the healthy groups, rather than lumping all of them into
one group in the estimation.
While the two-equation DPM model works well for data sets where the treatment group and
the control group are not too far apart from each other, a Roy-type model is warranted when the
imbalance between those two sub samples are substantial. Thus, in the second DPM model, I utilize
a three-equation Roy-type framework to model the observed heterogeneity that arises due to the
treatment status, while the unobserved heterogeneity is handled by separate DPM models for the
treated and untreated outcomes. I show that for the studied data the DPM model outperforms the
FMM. In addition, the DPM models automatically select the number of components within each
outcome to give the best model fit, bypassing the cumbersome task of trying out all the possible
combinations of number of components for both the control and the treatment groups under FMM.
Utilization of the low-level language C++ substantially improves the efficiency of the DP algorithm
boosting the computational speed by a factor of somewhere between 60 and 100 relative to R making
it well suited for implementing DP algorithms.
This Roy-type DPM model is applied to a data set consisting of 33, 081 independent individuals
from the Medical Expenditure Panel Survey (MEPS), and the treatment effects of having private
medical insurance on the outpatient expenditures are estimated. I find that there are strong incentive
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effects – those with insurance, on average, spend $799 more on outpatient care than those without
insurance. The posterior draws of most parameters show multimodality and substantial skewness,
especially in the treatment group, where the DPM model is able to generate more components, or
clusters, than that of the control group. The selection effect, however, is found to be quite small
after the heterogeneity is adequately modeled. This is similar to the finding of Conley et al. (2008)
who also report less “endogeneity” bias if more flexible function forms are specified on the error
terms.
6.2 Future Research
One idea for future research is to specify a FMM with a DP prior on the error terms. While DPM
gives better model fit, it does not give us results for each component, and sometimes we are inter-
ested in the estimates for those components. The idea behind this FMM-DP model is to let FMM
identify the components in the data, while the DP prior is employed to handle the unknown hetero-
geneity in the error terms. The model is specified as follows:
Di = Wiα+ ui (6.1)
Mi = Viγ+ξi (6.2)
Yij = Xiβj + ρjdi + δjui + εij (6.3)
with
εij ∼ G(αG0j)
The first two equations are the same as in MT2010, and a separate DP prior is specified on the
error term of each component as seen in equation (6.3), instead of the normal prior as in MT2010.
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I ran the model using the same data set as the one used in the DPM selection model. The
coefficients of the selection equation (6.2) show a high level of autocorrelation, and the model
seems quite unstable. There could be a couple of reasons for this phenomena. It is possible that
the selection equation is indeed misspecified given this data set; or the MNP selection mechanism
and DPM are working on the same source of heterogeneity, which makes the parameters on the
selection equation unidentifiable, which leads to the instability of the model. Future research in this
area should be quite interesting.
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Appendix A: Tables and Figures for the DPM Selection Model
Table 1: Varible Definitions and Summary Statistics: DPM Selection Model
Full sample No drug coverage Drug coverage
AAMTTOT 1687.85(1647.29) 1587.93(1563.75) 1924.75(1809.47)
LNAAMTTOT 6.95(1.15) 6.88(1.17) 7.11(1.11)
COVRX 0.30(0.46) 0.00(0.00) 1.00(0.00)
AGE 78.17(7.39) 78.36(7.27) 77.71(7.65)
MALE 0.40(0.49) 0.42(0.49) 0.36(0.48)
WHITE 0.95(0.22) 0.96(0.20) 0.93(0.25)
HEARTCOND 0.80(0.40) 0.79(0.41) 0.82(0.38)
OTHCOND 0.62(0.49) 0.61(0.49) 0.64(0.48)
MARRY 0.54(0.50) 0.54(0.50) 0.52(0.50)
WIDOW 0.39(0.49) 0.39(0.49) 0.40(0.49)
LVALONE 0.37(0.48) 0.36(0.48) 0.38(0.48)
CHNLNM 2.90(1.86) 2.88(1.86) 2.96(1.89)
MSA 0.63(0.48) 0.59(0.49) 0.71(0.46)
NOREAST 0.12(0.33) 0.11(0.31) 0.16(0.36)
WEST 0.12(0.33) 0.11(0.31) 0.16(0.37)
SOUTH 0.44(0.50) 0.46(0.50) 0.38(0.49)
VEGOOD 0.30(0.46) 0.30(0.46) 0.32(0.47)
GOOD 0.36(0.48) 0.37(0.48) 0.34(0.47)
FAIR 0.15(0.36) 0.14(0.35) 0.16(0.37)
POOR 0.04(0.20) 0.04(0.19) 0.05(0.22)
SMOKNOW 0.08(0.26) 0.08(0.27) 0.06(0.25)
SMOKEVER 0.56(0.50) 0.56(0.50) 0.54(0.50)
DEGRCV 4.69(1.95) 4.65(1.94) 4.79(1.96)
JOBSTAT 0.11(0.31) 0.11(0.31) 0.10(0.30)
LNINCOME 10.00(0.77) 9.98(0.76) 10.06(0.80)
YEAR2004 0.28(0.45) 0.29(0.46) 0.24(0.43)
YEAR2005 0.27(0.44) 0.21(0.41) 0.40(0.49)
PENET 7.38(10.82) 6.41(10.19) 9.68(11.89)
MOAMT 148.34(89.23) 136.85(64.95) 175.58(125.69)
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Table 2: Statistics for Sample Differences: DPM Selection Model
Imbens and Rubin 2007 T statistics
AGE -0.06 -1.88
MALE -0.09 -2.69
WHITE -0.07 -2.23
HEARTCOND 0.06 1.77
OTHCOND 0.03 1.07
MARRY -0.03 -1.07
WIDOW 0.01 0.37
LVALONE 0.02 0.54
CHNLNM 0.03 0.97
MSA 0.17 5.47
NOREAST 0.11 3.30
WEST 0.12 3.66
SOUTH -0.11 -3.39
VEGOOD 0.04 1.14
GOOD -0.05 -1.50
FAIR 0.03 0.95
POOR 0.05 1.41
SMOKNOW -0.04 -1.42
SMOKEVER -0.02 -0.75
DEGRCV 0.05 1.58
JOBSTAT -0.01 -0.46
LNINCOME 0.07 2.16
YEAR2004 -0.09 -2.77
YEAR2005 0.29 8.73
PENET 0.21 6.29
MOAMT 0.27 7.65
Table 3: Comparison of Estimates from Different Estimators: MCBS Dataset
Estimate
OLS 0.1163
OLS with Propensity Score 0.0020
Weighted GLM 0.0787
IV 1.1077
Heckman Two-Step 1.0263
Roy-type Model with Normal Errors 1.3170
DPM Selection Model 0.4568
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Table 4: Marginal Likelihood Results: DPM Selection Model
IS RI BS
Error -5525.39 -6199.62 -5935.81
Rho -5509.76 -6154.67 -5868.21
Both -5712.16 -6213.09 -5965.51
Mixed -5519.06 -6053.08 -5785.89
Table 5: Selection Equation Results: DPM Selection Model
Estimate Std. Error Pr(>|t|)
CONST(First Stage) -0.280 0.562 0.618
AGE(First Stage) -0.014 0.004 0.001
MALE(First Stage) -0.157 0.069 0.023
WHITE(First Stage) -0.367 0.131 0.005
HEARTCOND(First Stage) 0.081 0.074 0.277
OTHCOND(First Stage) 0.059 0.061 0.332
MARRY(First Stage) -0.058 0.126 0.648
WIDOW(First Stage) -0.029 0.119 0.805
LVALONE(First Stage) -0.005 0.087 0.953
CHNLNM(First Stage) 0.010 0.016 0.519
MSA(First Stage) 0.232 0.063 0.000
NOREAST(First Stage) 0.184 0.097 0.058
WEST(First Stage) 0.274 0.094 0.003
SOUTH(First Stage) -0.131 0.069 0.056
VEGOOD(First Stage) 0.096 0.092 0.298
GOOD(First Stage) 0.028 0.094 0.764
FAIR(First Stage) 0.150 0.110 0.172
POOR(First Stage) 0.261 0.159 0.100
SMOKNOW(First Stage) -0.115 0.116 0.322
SMOKEVER(First Stage) 0.011 0.065 0.861
DEGRCV(First Stage) -0.017 0.016 0.312
JOBSTAT(First Stage) -0.042 0.098 0.672
LNINCOME(First Stage) 0.042 0.043 0.332
YEAR2004(First Stage) 0.071 0.069 0.309
YEAR2005(First Stage) 0.530 0.069 0.000
MOAMT(First Stage) 0.003 0.000 0.000
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Table 6: Expenditure Equation Results: DPM Selection Model
Estimate Std. Error Pr(>|t|)
Number of Components 4.994 1.717 0.004
CONST 4.809 1.766 0.007
AGE -0.002 0.007 0.754
MALE -0.059 0.126 0.638
WHITE 0.194 0.210 0.355
HEARTCOND 0.539 0.406 0.184
OTHCOND 0.324 0.127 0.011
MARRY -0.061 0.204 0.764
WIDOW -0.026 0.178 0.886
LVALONE 0.029 0.140 0.837
CHNLNM 0.008 0.024 0.742
MSA -0.035 0.123 0.778
NOREAST 0.029 0.162 0.857
WEST 0.008 0.138 0.956
SOUTH 0.165 0.110 0.136
VEGOOD 0.135 0.129 0.297
GOOD 0.389 0.159 0.014
FAIR 0.653 0.309 0.035
POOR 0.594 0.281 0.035
SMOKNOW -0.179 0.213 0.403
SMOKEVER 0.047 0.128 0.710
DEGRCV 0.006 0.025 0.826
JOBSTAT -0.243 0.151 0.109
LNINCOME 0.092 0.069 0.180
YEAR2004 0.093 0.103 0.366
YEAR2005 0.276 0.126 0.029
COVRX 0.457 0.184 0.013
Covariance -0.236 0.150 0.116
Sigma 0.701 0.206 0.001
76
ps
M
O
AM
T
0
500
1000
1500
2000
0.2 0.4 0.6 0.8
Figure 1: Scatter Plot of Propensisty Score vs IV for DPM Selection Model
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Figure 2: Kernel Density Plot of Data for DPM Selection Model
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Figure 3: Density Plots of Data and Predicted Values for DPM Selection Model
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Figure 4: Auto Correlation Plots of Key Parameters for DPM Selection Model
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Figure 5: Trace and Density Plots of Key Parameters for DPM Selection Model
81
CONST
Si
gm
a
1
2
3
4
0 2 4 6 8
Figure 6: Posterior Scatter Plot of Intercept vs Variance for DPM Selection Model
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Figure 7: Posterior Scatter Plot of Intercept vs COVRX for DPM Selection Model
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Figure 8: Posterior Scatter Plot of Intercept vs Selection Bias for DPM Selection Model
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Figure 9: Density Plot of Treatment Effects for DPM Selection Model
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Figure 10: Density Plot of Treatment Effects for the Treated for DPM Selection Model
86
HEARTCOND
Te
a
tm
en
t E
ffe
ct
s
0
1000
2000
3000
4000
5000
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
ll
l l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l l
l l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
ll
l
l
l
l
l
l
l
l
l
l
l l
l
l
ll
l
l ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
ll
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
ll
ll
l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l
ll
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0.0 0.5 1.0
Figure 11: Posterior Jitter Plot of TE vs HEARTCOND for DPM Selection Model
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Figure 12: Posterior Jitter Plot of TE vs OTHER COND for DPM Selection Model
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Appendix B: Tables and Figures for the Roy-type DPM Model
Table 7: Varible Definitions and Summary Statistics: Roy-type DPM Model
Full sample No Insurance With Insurance
Sample Size 33081 4219 28862
OUTEXP 2331.15(4252.68) 1229.96(2773.06) 2492.12(4404.78)
LOUTEXP 6.85(1.46) 6.04(1.52) 6.97(1.41)
PRVEV 0.87(0.33) 0.00(0.00) 1.00(0.00)
YEAR03 0.12(0.33) 0.12(0.32) 0.12(0.33)
YEAR04 0.12(0.32) 0.13(0.33) 0.12(0.32)
YEAR05 0.11(0.32) 0.13(0.33) 0.11(0.32)
YEAR06 0.13(0.33) 0.14(0.34) 0.12(0.33)
YEAR07 0.10(0.30) 0.10(0.29) 0.10(0.30)
YEAR08 0.14(0.35) 0.16(0.37) 0.14(0.34)
VEGOOD 0.34(0.47) 0.27(0.45) 0.35(0.48)
GOOD 0.28(0.45) 0.33(0.47) 0.27(0.44)
FAIRPOOR 0.11(0.31) 0.19(0.39) 0.09(0.29)
PHYSLIM 0.07(0.25) 0.08(0.27) 0.06(0.24)
FAMSZEYR 3.02(1.49) 3.26(1.73) 2.99(1.44)
AGEX 4.29(1.04) 4.05(1.06) 4.33(1.04)
EDUCYR 13.44(2.79) 11.46(3.25) 13.73(2.59)
FEMALE 0.55(0.50) 0.54(0.50) 0.55(0.50)
BLACK 0.14(0.35) 0.17(0.37) 0.14(0.35)
HISP 0.17(0.38) 0.39(0.49) 0.14(0.35)
MARRY 0.67(0.47) 0.52(0.50) 0.69(0.46)
NOREAST 0.16(0.37) 0.10(0.30) 0.17(0.37)
MIDWEST 0.23(0.42) 0.15(0.35) 0.24(0.43)
SOUTH 0.37(0.48) 0.48(0.50) 0.36(0.48)
MSA 0.83(0.38) 0.79(0.41) 0.83(0.37)
INCOME 71.57(50.02) 39.89(33.82) 76.20(50.33)
FIRMSIZE 16.88(18.94) 8.30(14.15) 18.13(19.22)
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Table 8: Statistics for Sample Differences: Roy-type DPM Model
Imbens and Rubin 2007 T statistics
YEAR03 0.01 0.93
YEAR04 -0.02 -1.39
YEAR05 -0.03 -2.28
YEAR06 -0.03 -2.21
YEAR07 0.01 0.54
YEAR08 -0.05 -4.19
VEGOOD 0.12 10.61
GOOD -0.09 -7.86
FAIRPOOR -0.20 -15.75
PHYSLIM -0.05 -3.84
FAMSZEYR -0.12 -9.89
AGEX 0.19 15.79
EDUCYR 0.54 43.24
FEMALE 0.00 0.28
BLACK -0.06 -4.90
HISP -0.42 -32.06
MARRY 0.25 20.99
NOREAST 0.14 13.23
MIDWEST 0.17 15.76
SOUTH -0.18 -14.80
MSA 0.07 6.11
INCOME 0.60 60.61
FIRMSIZE 0.41 40.07
Table 9: Comparison of Estimates from Different Estimators: MEPS Dataset
Estimate
OLS 0.7005
OLS with Propensity Score 0.6296
Weighted GLM 0.6120
IV 1.5641
Heckman Two-Step 1.4248
Roy-type Model with Normal Errors 1.6796
Roy-type DPM Model 0.5975
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Table 10: Marginal Likelihood Results: Roy-type DPM Model
IS RI BS
error -98331.91 -99861.89 -98685.61
rho -96197.51 -99189.61 -97026.69
mixed -82225.64 -88136.32 -82327.33
2 components -98333.57 -99440.19 -98781.91
3 components -93602.16 -96285.69 -95497.31
4 components -88948.96 -92202.41 -89781.95
5 components -85574.08 -92579.34 -87769.80
6 components -84189.61 -89184.13 -84981.33
7 components -84447.17 -90142.50 -85352.30
Table 11: Selection Equation Results: Roy-type DPM Model
Estimate Std. Error Pr(>|t|)
CONST(First Stage) -0.514 0.080 0.000
YEAR03(First Stage) -0.086 0.035 0.021
YEAR04(First Stage) -0.127 0.033 0.001
YEAR05(First Stage) -0.096 0.055 0.094
YEAR06(First Stage) -0.135 0.051 0.013
YEAR07(First Stage) -0.153 0.038 0.000
YEAR08(First Stage) -0.202 0.033 0.000
VEGOOD(First Stage) 0.031 0.026 0.246
GOOD(First Stage) -0.064 0.027 0.027
FAIRPOOR(First Stage) -0.203 0.035 0.000
PHYSLIM(First Stage) -0.017 0.039 0.661
FAMSZEYR(First Stage) -0.080 0.007 0.000
AGEX(First Stage) 0.067 0.010 0.000
EDUCYR(First Stage) 0.070 0.004 0.000
FEMALE(First Stage) 0.068 0.020 0.002
BLACK(First Stage) -0.074 0.028 0.014
HISP(First Stage) -0.362 0.026 0.000
MARRY(First Stage) 0.340 0.023 0.000
NOREAST(First Stage) 0.151 0.034 0.000
MIDWEST(First Stage) 0.152 0.031 0.000
SOUTH(First Stage) -0.087 0.027 0.003
MSA(First Stage) 0.068 0.025 0.012
INCOME(First Stage) 0.008 0.000 0.000
FIRMSIZE(First Stage) 0.014 0.001 0.000
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Table 12: Outcome Equation Results: Roy-type DPM Model
Control Treated
Sigma 1.119(0.2137) 0.8009(0.3054)
Covariance -0.005(0.0872) -0.0110(0.0445)
Intercept 4.221(0.6964) 4.8143(1.2675)
YEAR03 -0.099(0.0858) 0.1973(0.0802)
YEAR04 0.002(0.1188) 0.2716(0.0687)
YEAR05 0.085(0.0764) 0.1096(0.0794)
YEAR06 0.090(0.0643) 0.2571(0.0877)
YEAR07 0.123(0.0922) 0.3473(0.0945)
YEAR08 0.175(0.1265) 0.3001(0.0861)
VEGOOD 0.152(0.0501) 0.2615(0.0750)
GOOD 0.342(0.0560) 0.4878(0.1018)
FAIRPOOR 0.645(0.1574) 0.9410(0.1999)
PHYSLIM 0.449(0.0865) 0.6068(0.1188)
FAMSZEYR -0.041(0.0200) -0.0913(0.0370)
AGEX 0.231(0.0283) 0.2423(0.0720)
EDUCYR 0.045(0.0077) 0.0365(0.0139)
FEMALE 0.233(0.0630) 0.3689(0.1050)
BLACK -0.223(0.0584) -0.3037(0.1072)
HISP -0.278(0.0828) -0.2900(0.0978)
MARRY 0.125(0.0860) 0.0903(0.0841)
NOREAST -0.049(0.0801) 0.0642(0.0733)
MIDWEST -0.081(0.0608) 0.1813(0.0652)
SOUTH -0.044(0.0540) 0.0483(0.0466)
MSA -0.022(0.0492) 0.0165(0.0502)
INCOME 0.004(0.0006) 0.0009(0.0007)
DP Precision 0.721(0.3669) 1.6481(0.7260)
Number of Components 7.971(2.6378) 17.4576(5.9086)
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Figure 13: Kernel Density Plot of Data for Roy-type DPM Model
93
LOUTEXP
D
en
si
ty
0.05
0.10
0.15
0.20
0.25
0.05
0.10
0.15
0.20
0.25
Full
Treatment
0 2 4 6 8 10 12
Control
0 2 4 6 8 10 12
Type
Data
Predicted Value
Figure 14: Density Plots of Data and Predicted Values for Roy-type DPM Model
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Figure 15: Auto Correlation Plots of Key Parameters for Roy-type DPM Model: Control Group
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Figure 16: Auto Correlation Plots of Key Parameters for Roy-type DPM Model: Treatment Group
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Figure 17: Trace and Density Plots of Key Parameters for Roy-type DPM Model: Control Group
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Figure 18: Trace and Density Plots of Key Parameters for Roy-type DPM Model: Treatment Group
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Figure 19: Posterior Scatter Plot of Intercept vs Variance for Roy-type DPM Model
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Figure 20: Posterior Scatter Plot of Intercept vs Selection Bias for Roy-type DPM Model
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Figure 21: Posterior Scatter Plot of Intercept vs MARRY for Roy-type DPM Model
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Figure 22: Density Plot of Treatment Effects for Roy-type DPM Model
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Figure 23: Density Plot of Treatment Effects for the Treated for Roy-type DPM Model
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Figure 24: Posterior Scatter Plot of TE vs INCOME for Roy-type DPM Model
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Figure 25: Posterior Scatter Plot of TE vs EDUCYR for Roy-type DPM Model
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Figure 26: Posterior Scatter Plot of TE vs AGEX for Roy-type DPM Model
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